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 Obesity and metabolic syndrome are a rising worldwide epidemic and have driven 
a subsequent increase in prediabetes and type 2 diabetes. We now know that patients who 
have prediabetes will begin to develop debilitating alterations in sensation due to early 
damage of peripheral sensory axons. There have been few therapies proposed to help 
patients developing metabolic syndrome induced painful neuropathies and those that have 
been developed often exhibit minimal benefit. While the mechanisms of prediabetes-
induced peripheral neuropathy are still poorly understood, previous work has been able to 
show there is a significant benefit from physical activity that improve abnormal sensation 
and pain.  
 Early studies in this work demonstrate that exercise alters the metabolic status of 
peripheral neurons and can normalize heightened mechanical sensitivity induced by a 
high fat diet. Utilizing a genetic rat model of differing intrinsic aerobic levels, our results 
show that genetic differences that result in varied metabolism alters peripheral nerve 
function and sensation. Highlighting the importance of metabolism, our studies show that 
exercise increases the utilization of fat based fuels, providing a novel mechanism for 
improved sensation. We performed studies in mice utilizing a ketogenic diet that is high 
in fat and low in carbohydrates to push fat utilization in nerves. These studies revealed 
that consumption of a ketogenic improved abnormal peripheral sensation. Contrary to 
exercise or a control diet, a ketogenic diet was able to prevent and also reverse high fat 




increased axonal growth in vitro and in vivo. This exciting result of improved nerve 
growth has the potential to benefit millions of patients worldwide experiencing 
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Twenty-five million Americans are encumbered by acute pain and over 50 million 
suffer from varying chronic pain syndromes, leading to a medical cost of over $635 
billion a year 1. This enormous health plight highlights the need to find novel 
interventions to reduce the burden of chronic pain. Generally speaking, chronic pain 
includes changes in peripheral tissues, such as the hands and feet, and the central nervous 
system, which often leads to even more debilitating and chronic effects disease 
progresses 2,3. The perception of pain is a broad and complex mechanism to study, having 
multiple origins including nerve damage, metabolic disease, and numerous others. Each 
form of pain may be unique not only in its development but also in the treatments 
necessary to provide relief. Unfortunately, current therapies available for the treatment of 
these pain states are still associated with pain abatement and do not address underlying 
mechanisms driving the development of varying forms and levels of sensory discomfort 
4.  
 Physical activity offers a wide array of benefits and is well documented to help in 
a myriad of diseases, however the specific mechanisms by which exercise exerts its 
benefits are poorly understood in the nervous system. The complexities of understanding 
how global cross organ communication and changes induce molecular changes to provide 
benefits in disease makes exercise research often hard to perform on a basic level. 





 Nociceptive and neuropathic pain syndromes both receive physiological and 
behavioral benefits from exercise intervention, even though they are thought to have 
separate physiological characteristics. Nociceptive pain results from an expected noxious 
stimulus, while neuropathic pain occurs in the absence of a stimulus, or with a normally 
innocuous stimulus. The neuronal pathway of nociceptive pain starts with a noxious 
stimulus detected by a peripheral sensory peripheral terminal of an Aδ- or C-fiber. The 
electrical signal is then propagated up through spinal and thalamic pathways to terminate 
in an appropriate somatotopic region of the cortex 5. In the case of neuropathic pain, 
adaptations occur in Schwann cells, satellite cells, the peripheral immune system, spinal 
microglia, and astrocytes that lead to the development of a painful syndrome when one 
would not normally exist 6. Important areas to examine in these pain pathways are 
interneuronal interactions and the molecular and cellular changes that are initiated within 
them. This is an important aspect of any therapeutic target for pain due to the activity-
dependent neuronal plasticity that occurs in the nervous system 7. 
In response to new information about neuronal activity-dependent plasticity, a 
new and rapidly growing area within both pain research and neural physiology has begun 
to examine the effects of exercise on peripheral and central nervous system components. 
However, the scarcity of well-controlled basic research in this area hampers the 
utilization of exercise as a therapy for neuropathic and other chronic pain syndromes. 
While exercise intervention is growing quickly as a clinical therapeutic tool for many 
diseases, its use to reduce pain states is still relatively new and the research available 




therefore is vital to gain a better understanding of how exercise benefits the management 
of various pain syndromes and for the implementation of this therapeutic technique on a 
broader scale by physicians.  
Sensory Pathways Sensitive to Exercise 
 A well-established effect of exercise is its firing of afferent sensory nerves from 
contracting muscles to the spinal cord. Signaling in sensory fibers of working muscles is 
increased during exercise and provides important feedback on the cardiovascular and 
respiratory systems during physical activity 8. One example of afferent nerve activity 
affected by exercise is the exercise pressor reflex (EPR), which is responsible for the 
control of blood pressure and heart rate (HR) changes during physical activity through 
sympathetic nerve activation 9,10. This reflex is partially mediated by the transient 
receptor potential vanilloid 1 (TRPV1) receptor, the sensory receptor respondent to 
capsaicin that is stimulated from temperature and pH level changes 11. Similar to TRPV1, 
the acid sensing ion channel 3 (ASIC3) found on sensory nerve terminals in active 
skeletal muscle is involved in the regulation of arterial pressure through the EPR 12. 
However, EPR is additionally modulated by sodium channel (Nav) function; these 
channels in turn, may be modulated through reactive oxygen species levels in the dorsal 
root ganglion (DRG) 13. The EPR sensory pathway intersects with known painful sensory 
pathways through the TRPV1, ASIC3 and sodium channel alterations; this cross talk can 
provide possible avenues by which exercises known benefits may also connect to painful 




 Studies now demonstrate that exercise can induce molecular and cellular changes 
in DRG sensory neurons. The benefits of exercise can appear quickly as evidenced by 
improvements in regeneration after nerve injury following 3 - 7 days of exercise 14.  This 
effect may be related to increased production of a number of molecular signals, including 
brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 
(NT-3), synapsin I (SNAP1), and growth associated protein 43 (GAP43) in sensory 
ganglia, thereby stimulating axonal growth 14,15. Consistent with this idea, exercised 
animals display alterations in molecular mediators in their DRGs. Large DRG neurons 
undergo changes in mRNA expression that are associated with neuronal plasticity and 
apoptosis in response to prolonged exercise, including higher BDNF, NT3, SNAP1, and 
GAP43 mRNA levels compared to sedentary animals 16. Exercise of animals that have 
been given a high fat diet suggests that exercise can reverse alterations in neurotrophin 
expression that are associated with a high fat diet, insulin resistance and pain 17. For 
example, exercise of diabetic mice induces significant increases in GDNF protein in the 
spinal cord and sciatic nerve, along with axonal transport in the sciatic nerve (Wright, 
unpublished observations).  
Our own studies suggest that exercise can induce important phenotypic changes 
can occur in peripheral terminals of epidermal axons 17. A high fat diet increases the 
number of epidermal axons that express tropomyosin receptor kinase A (TrkA), the high 
affinity receptor for nerve growth factor (NGF). This phenotypic change in peripheral 
axons corresponds to an increase in pain thresholds of the mice. Importantly, however, 




Finally, Schwann cell proliferation is increased following exercise and may play an 
important role in the increase in axonal regeneration necessary for appropriate response 
to peripheral nerve injury The benefits seen with peripheral nerve regeneration are 
significant enough to improve functional and morphological markers of nerve and motor 
function post exercise 18. These studies bolster the idea that axonal regeneration responds 
positively to exercise.  
Exercise’s benefits are not only limited to the periphery, as they also display a 
substantial value to the central nervous system. The numerous benefits of exercise on 
both the peripheral and central sensory nervous system are highlighted in Figure 1. 
Centrally, the brain imparts bi-directional control of pain processing and pain modulation 
that alters the transmission and perception of pain and sensation 19. The effects of 
physical activity on this system are grossly understudied and this important central 
modulation of pain and sensation would benefit by continued examination of the 
metabolic, inflammatory, and ionic changes within the CNS.  
Although only a few studies have been published, regular physical exercise has 
been reported to prevent the development of chronic muscle pain and exercise induced 
muscle pain. Postulated mechanisms include reducing phosphorylation of the NR1 
subunit of the N-methyl-D-aspartate (NMDA) receptor in the brainstem, modulating 
nociception and individual experiences 20. An additional potential mechanism is the nitric 




nitrate levels which in turn provides an antinociceptive benefit during physical activity 21-
23.  
Centrally, exercise increases the endogenous opioid content in brainstem regions 
important in pain modulation, suggesting that exercise-induced reversal of neuropathic 
pain may include an up-regulation of endogenous opioids 24. This may be a key analgesic 
mechanism as patients with chronic pain display a reduced endogenous pain inhibition 
system and creating an imbalance between pain modulation systems 19. This highlights 
another benefit of exercise whereby it can increase endogenous analgesic systems known 
to be critically important in modulating pain. However, the endogenous opioid system 
however has been disputed in its role in modulating internal antinociceptive effects 
during physical activity 25,26. This group has instead suggested the endogenous 
endocannabinoid system is playing a prominent role in the antinociceptive benefits of 
exercise 27,28. There is a definitive need to explore these endogenous systems that are 
sensitive to exercise and play a prominent role in anti-nociception.   
The primary benefits of physical activity may have an additive effect when paired 
with pharmacological interventions. The osteoporosis drug risedronate combined with 
treadmill running decreases sensory nerve calcitonin gene-related peptide (CGRP) 
expression when compared to rats receiving only the drug 29. In conclusion, while 
exercise is often thought of as a preventative intervention, there also appears to be a clear 
benefit after injury. The benefits of exercise affect the nervous system at multiple levels 




the molecular pathways that seem sensitive to, including axonal growth, altered 
neurotrophin levels, and phenotypic changes in both the periphery and central 



















Figure 1: Overview of the positive changes induced by physical activity that benefit 
sensation. 
Cooper et al. 2016, Emerging Relationships between Exercise, Sensory Nerves, and 
























Experimental Studies of Neuropathic Pain and Exercise 
Many of these studies discussed above have centered on the ability of exercise to 
alleviate neuropathic pain associated with diabetes, as painful diabetic neuropathy (DPN) 
is an optimal condition in which exercise can have widespread benefits 30. Table 1 
highlights studies in rodents in which exercise was used as an intervention to treat pain. A 
delay in onset of diabetes-associated neuropathy with continuous exercise may be 
associated with changes in calcium channel function in the DRG allowing for an 
alteration in nociceptive signaling from the periphery 31. Additional benefits such as 
increased motor nerve conduction velocities occur in diabetic patients, modifying or 
delaying the natural course of diabetic peripheral neuropath 32. The mechanism by which 
exercise alleviates neuropathic pain is still unknown and may be the combination of 
many changes driven by physical activity. This may especially be true in instances where 
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 In a type I rodent model of DPN, running is able to reduce several modalities of 
allodynia, including mechanical, cold, and heat hyperalgesia. Key molecular markers 
such as TRPV1 (heat) and transient receptor potential cation channel subfamily M 
member 8 (TRPM8) are associated with allodynia33. Forced running leads to changes in 
these channels that is associated with pain reduction. Voluntary aerobic exercise reduces 
nociceptive symptoms to basal levels at early stages of diabetes such as pre-diabetes 
induced by a high-fat diet 17.  
However, researchers and clinicians must be careful not to exceed the level of 
exercise at which activity is no longer a therapeutic tool. There is evidence that exercise 
can increase negative outcomes in some instances. An overzealous training protocol can 
lead to the loss of many benefits seen with physical activity due to the bodies self-
protection through activation of glial cells in both motor and sensory systems 34. 
Though diabetes is the most researched disease relative to exercise and 
neuropathic pain; physical activity is a useful therapeutic tool for a myriad of painful 
diseases. Paclitaxel-induced neuropathy frequently occurs in patients undergoing 
chemotherapy and induces a loss of sensation and sensory fiber loss in the skin. 
Treadmill exercise reduces sensory loss and increases epidermal nerve fiber density in 
paclitaxel-treated mice 35. Additional results include the ability of exercise to decrease 
abnormal levels of detyrosinated tubulin in paclitaxel-treated nerves, highlighting 
important anti-neurotoxic effects of exercise 35. Other studies have shown that moderate 




(NT-3), which acts in an analgesic fashion in a number of different pain conditions 36. In 
studies of spinal cord injury associated pain, treadmill training improves sensory 
function, ameliorated allodynia, and restored normal sensation after within 5 weeks of the 
spinal cord injury 37. Physical activity not only improved pain scores, but also improved 
tissue health through increased phagocytic clearance in glial cells 38. This finding 
suggests that rhythmic, weight-bearing exercise may be an effective intervention to 
counter spinal cord injury induced allodynia.  
Varying modes and intensities of exercise have been tested to treat neuropathic 
pain, almost all of which have a positive effect 20,24,31,32,36,37,39. However, not all forms 
and types of exercise provide the same type or degree of benefit, particularly related to 
the intensity of exercise 40. For instance, treadmill running increases neurite outgrowth 
with low intensity but not high intensity exercise levels. However, studies have not 
rigorously investigated how varying modes of exercise impact a single model and a 
single sensory dysfunction. This is likely because researchers focus on a single exercise 
modality throughout their research study for consistency and control among experimental 
studies.  
While aerobic exercise is the most commonly modality studied, even less 
common forms of exercise such as swimming provide a benefit to the nervous system. 
Swimming provides positive results as a therapy for induced nerve injury in rats, 
reducing both mechanical allodynia and thermal hyperalgesia 41. In addition, swimming 




and nerve injury-induced animal models of persistent pain 39. The mechanism by which 
swimming exercise reduces mechanical allodynia may involve endogenous adenosine 
and adenosine A1 receptors 42. It is reported that agonists to the adenosine A1 receptor 
reduce mechanical allodynia in a neuropathic pain model of diabetes, suggesting another 
possible mechanism in which exercise may reduce pain 43. These positive results from 
swimming offer an attractive exercise for patients with neuropathic pain due to the 
reduced load on pain-affected extremities and problems with coordination many patients, 
especially in elderly patients. For this reason, additional research in swimming regimens 
is needed to understand benefits for neuropathic pain, as its utilization could be the best 
avenue for relief for many patients.  
 Just as exercise intensity and mode may be key factors in the benefits of physical 
activity, time of exercise onset and duration may prove to be important as well. Intense 
short-burst exercise significantly reduced mechanical allodynia in a chronic constriction 
injury model of neuropathic pain, resulting in better recovery of sensorimotor function 44. 
The relationship of time between the onset of injury and the start of exercise is not clear, 
however, there are multiple studies that have reported positive results with exercise 
starting within one week of injury. Initiation of treadmill running 3 days after an induced 
injury had an immediate and long-lasting reduction in pain that was independent of the 
duration of exercise 45. Exercise training beginning 5 days after injury was sufficient to 
prevent the development of neuropathic pain 46. Also, exercise initiation 7 days after 




studies suggest that there may be no need to wait for a certain amount of time to pass 
after injury before the introduction of exercise as a therapeutic aide.  
The Relationship of Inflammation and Exercise 
The immune and nervous systems interact substantially in chronic pain states via 
immune cells, glia and neurons that coordinate immune responses and the excitation of 
the pain pathway. Many of these interactions include the synthesis and release of 
inflammatory mediators and neurotransmitters 47. When injured, damaged tissue will 
signal mast cell degranulation and pro-inflammatory cytokine release such as tumor 
necrosis factor alpha (TNF- α) and interleukin 1 beta (IL1-β). Additional actions include 
increased NGF signaling via TrkA that enhances substance P release and pain signal 
propagation in the spinal cord. In response to peripheral tissue injury, immune cells also 
synthesize and secrete anti-inflammatory cytokines (IL-10 and IL-6), pro-resolution lipid 
mediators and opioid peptides to suppress the pain from pro-inflammation cytokines 48,49. 
Many of these pro-inflammatory signals are present acutely after exercise, however, 
chronic examination of these markers post-exercise often show a robust anti-
inflammatory signaling cascade in response to these acute pro-inflammatory markers 50. 
Overall, however, the chronic effects of exercise on inflammation are still viewed as 
beneficial to reduce inflammatory signaling in disease 51. For this reason, exercise has 
been utilized as an intervention that can activate natural anti-inflammatory mechanisms 
that causes cells to secrete anti-inflammatory cytokines that suppress the pain induced by 




Numerous cytokines (interleukin 1 alpha (IL1- α), IL1-β, interleukin 2 (IL-2), 
interleukin 4 (Il-4), interleukin 6 (IL-6), interleukin 10 (IL-10), interferon gamma (IFN-
γ), transforming growth factor beta (TGF-β), TNF-α) become active in the spinal cord 
and DRG during neuropathic pain 53-57. Pro-inflammatory cytokines have been implicated 
in neuropathic and inflammatory nociceptive conditions in a wide array of research 58. 
The most prominently studied inflammation marker, TNF-α, has been implicated as 
having a key role in both the peripheral and central mechanisms of sensitization to 
painful stimuli 59. Due to their recurring presence during painful stimuli, inflammatory 
cytokines have been investigated for a mechanism by which exercise reduces allodynia 
60.  
A prominent benefit of both endurance and resistance exercise programs is their 
reduction of pro-inflammatory cytokines and increases in anti-inflammatory markers 
(Figure 2) 61. The pro-inflammatory acute effects of exercise are proposed to cause a 
subsequent spike in anti-inflammatory cytokines that are long-lasting after completion of 
the exercise bout. Regular exercise has been found to decrease inflammatory markers in 
both young and older humans 62-65. During and after exercise, increases in levels of IL-6 
appear to drive a subsequent rise in levels of anti-inflammatory cytokines such as IL-10 
and IL-1 receptor agonist (IL-1RA) 66. IL-6 has been described as a myokine, a cytokine 
that is released from muscle fibers during contraction while exerting its effects on other 
organs 67. When given as an intravenous infusion, IL-6 provide anti-inflammatory effects 




suggesting that IL-6 levels are the cause of anti-inflammatory benefits seen from exercise 
68.  
Anti-inflammatory markers respond to the rise in IL-6 induced by exercise and 
have compounding effects that can cause a decrease in allodynia. Increases in IL-10 are 
able to decrease the expression of pro-inflammatory cytokines and, in-turn, increase the 
ability of T cells to provide inflammatory responses 69. In mice that exercise via running 
wheels, T cells were increased in number and associated with a reduction in pro-









Figure 2: A) Overview of the inflammatory alterations in the sensory nervous system of 
rodents. Inflammatory cytokines are increased throughout the DRG, spinal cord, and 
peripheral tissues during numerous pain states, which is associated with the development 
of mechanical and thermal hypersensitivity. 
B) Anti-inflammatory signaling observed in the sensory nerves of exercised rodents. 
Exercise’s anti-inflammatory signals may reduce pro-inflammatory cytokines; while 
increasing heat shock proteins and T-cells leading to reduced mechanical and thermal 
hypersensitivity normally associated with inflammation.   
Cooper et al. 2016, Emerging Relationships between Exercise, Sensory Nerves, and 














Research showing a decrease in allodynia and hyperalgesia due to exercise 
intervention suggests that the alterations in nociception are strongly influenced by the 
increased anti-inflammatory and decreased pro-inflammatory cytokines. For example, 
forced treadmill running reduces substance P, IL-6, TNF- α, NR1 and IL-1β levels after 
the development of mechanical allodynia induced by skin/muscle incision and retraction 
71,72. Swimming and treadmill exercise decrease mechanical allodynia, cold allodynia, 
and heat hyperalgesia while also decreasing TNF- α and IL1-β production 33,73. Diabetes 
associated neuropathic pain is markedly reduced by progressive exercise training, 
possibly mediated by an increase of heat shock protein-72 (HSP72) without increases in 
TNF- α and IL-6 74. HSP72 is suggested to have a role in the inhibition of TNF- α and IL-
6 as well as many other cytokines 75. A greater expression of HSP72 and a reduction in 
diabetes-associated neuropathic pain, including thermal hyperalgesia and mechanical 
allodynia is seen after exercise 74. HSP72 has an essential role in blocking inflammation 
and insulin resistance associated with a high-fat diet that can lead to type 2 diabetes 76. 
Extended swimming reduces mechanical allodynia and thermal hyperalgesia in rats with 
formalin and nerve injury-induced inflammatory pain 39. In conclusion, the interactions 
between release of pro-inflammatory cytokines and exercise’s anti-inflammatory role via 
the up-regulation and release of anti-inflammatory myokines provides a mechanism that 






Exercise & Ketones 
Exercise exerts a myriad of effects on the body; however, some of the most potent 
signaling effects of exercise are due to alterations in bioenergetics and fuel demands. The 
natural role of ketone bodies in both disease and exercise focuses around bioenergetics 
demand and fuel production. The production of ketone bodies occurs naturally in the liver 
following reduced carbohydrate consumption and/or the body recognizing reduced 
bioenergetic availability. Fat stores in the body are taken to the liver and through beta-
oxidation are metabolized into acetoacetate, acetone, and beta-hydroxybutyrate. These 
ketone bodies an important fuel source as they can be transported to and burned by 
tissues which are unable/prefer not to utilize fat as a fuel source including the brain, 
heart, and skeletal muscle 77. This metabolic function of an alternative fuel source is an 
evolutionary trait, which has been conserved primarily due to the brain’s inability to 
utilize fat as a primary fuel source. Thus, the brain and other peripheral tissues must 
utilize fat fuel sources for survival in low energy or low carbohydrate states.  
Ketogenesis begins when natural metabolic signals such as glucagon to insulin 
ratios or reduced hepatic glycogen content reach critical levels. These same natural 
signals of prolonged fasting, or reduced energy intake are also stimulated during and 
following exercise bouts 78. When the natural energy demands of exercise exceed the 
carbohydrate based energy stores of skeletal muscle and other peripheral tissues, ketone 
production and utilization occurs as a prolonged fasting state, leading to down-stream 




utilization (Fig. 3). The study of ketone production and utilization during exercise focuses 
almost entirely on skeletal muscle, as it is the key peripheral tissue exerting a metabolic 
demand during exercise. For my own work the peripheral alterations in skeletal muscle 
should reasonably mirror alterations in peripheral nerves as well, which should rely and 
process responses to depletion in glycogen stores during high-energy demand periods79. 
There is evidence that ketone utilization would be higher in nerves than skeletal muscle, 
as the utilization of ketones is a requirement for the brain and excessive utilization in 
muscle would hinder this survival instinct 80,81.  
While ketones will be drawn from the blood for an alternative fuel source during 
exercise, the post exercise absorption period can be 10x greater than during exercise in 
skeletal muscle 82. The amount of ketones taken up following exercise is proportional to 
the intensity of the exercise and the depletion of glycogen in response to the exercise 
demands during exercise driving peripheral tissues to utilize ketones as an alternative fuel 
source post exercise until glycogen stores are restored 83. Ketone metabolism itself is not 
necessary post exercise, as glucose can meet energy demands when not performing 
physical activity. However, if ketones were not used post exercise there would not be an 
inhibition the use of glucose allowing for increased glycogen store replenishment in 
skeletal muscle which is a key metabolic priority post exercise 84. This highlights the 
strong nutritional demand control which exercise exerts on ketone production and uptake 
in peripheral tissues. The continued low glucose presence in the liver may continue to 




In addition to being a key nutritional metabolite during and following exercise, 
the ketone beta-hydroxybutyrate is an inhibitory signal for histone deacetytlases 
(HDACs)85. HDACs have numerous functions, however in relation to exercise, HDAC 
phosphorylation drives exercise responsive genes to increase, which highlights another 
crucial role for ketones and exercise in signaling 86. The ability to inhibit HDACs can 
alter gene expression, which in turn can lead to signaling and tissues alterations for a 
wide array of effects. While the effects of ketone signaling on HDACs in response to 
exercise has still only been weakly linked, the effects of beta hydroxybutyrate on HDAC 



















Figure 3: Overview of the downstream signaling effects of ketone bodies in peripheral 
tissues.  
Evans et al. 2017 Metabolism of ketone bodies during exercise and training: 





















Ketogenic Diet & Nerves 
 A ketogenic diet has been researched and used to treat central nervous system 
diseases for hundreds of years. A ketogenic diet was ascribed to epilepsy by Hippocrates 
and even the Book of Matthew in the bible 77. In more modern research, a ketogenic diet 
has been used to treat other nervous system diseases such as type 1 and type 2 diabetes, 
cardiovascular disease, glioblastoma, Alzheimer’s disease, amyotrophic lateral sclerosis, 
concussion and traumatic brain injuries, and autism 87-95. Traditionally, the role of the 
ketogenic diet in the nervous system was focused on fasting states when the brain 
required energy and was unable to consume carbohydrates. Ketogenesis primarily occurs 
in the liver and ketones are shuttled to the CNS for energy during low carbohydrate 
states, however recent research has also shown astrocytes can perform ketogenesis and 
produce ketones 96-98. 
  While the role of a ketogenic diet in disease has been heavily researched in the 
central nervous system, there is limited literature on the role of ketone metabolism on 
peripheral nerves. Metabolic improvements in liver and muscle in patients with metabolic 
syndrome indicate that a ketogenic may benefit peripheral nerves similar to other 
peripheral tissues. There has only been limited research examining the effects of a 
ketogenic diet on peripheral sensitivity and pain, and the mechanism by which a 
ketogenic diet may benefit the nerves is not yet understood.  
 In the sensory nervous system, recent investigations into the effects of a ketogenic 




the benefits and disadvantages of a ketogenic diet 99-102. One proposed mechanism for a 
reduction in pain is an increase in anti-inflammatory signaling induced by a ketogenic 
diet 103. In the present research, this mechanism is also attractive as both a ketogenic diet 
and exercise are able to produce an anti-inflammatory signaling cascade allowing for a 
potential rescue of the chronic inflammation often observed with a high-fat diet 100.  
Ketone metabolism increases peroxisome proliferator activated receptors in 
various tissues that results in reduced inflammatory states 104,105. Ketone-based 
metabolism is a much better metabolic process as compared to glucose metabolism at a 
mitochondrial and cellular level as it produces less reactive oxygen species (ROS) 106. In 
neurons, reductions in ROS due to caloric restriction/ketone signaling occurs in Complex 
I of the respiratory chain. In the brain, ketones inhibit reactive oxygen species production 
through an increase in NAD/NADH ratios during metabolism of beta-hydroxybutyrate as 
compared to glutamate 107. This alteration in NAD/NADH ratio activates Sirt1, which 
inhibits apoptotic and inflammatory signaling and promotes increase mitochondrial 
biogenesis. There is also increases in uncoupling proteins (UCPs) that increase leakage of 
protons across the matrix and reduce the electrical gradient across the membrane and 
ROS production 108. This improved mitochondrial respiration may combat mitochondrial 
changes associated with increased calcium signaling from neuronal injury and improve 
neuronal health and healing. 
A final key anti-inflammatory mechanism is via potential increases in adenosine 




through Sirt1 signaling and in turn has shown increased ATP in the brain of animals on a 
ketogenic diet 109. In neurons, low glucose levels induced by a ketogenic diet drives a 
release of ATP (produced through ketone metabolism in the neuron) released from cells 
and degraded to adenosine. Released ATP can be taken up by the cell again or signal 
through the adenosine receptor (A1R). This increase in ATP production is also associated 
with an increase in neural adenosine levels and adenosine itself has shown anti-
inflammatory affects, and is a known powerful modulator of pain 110. Activation of A1R 
on immune cells reduces the production of pro-inflammatory cytokines and has shown 
anti-inflammatory benefits in neuronal tissues and disease 111. Together these key 
metabolic pathways may all connect to mirror many powerful effects of exercise in the 
modulation and control of dietary induced pain.  
Conclusion 
 The use of exercise as a therapeutic tool is a rapidly growing field in biomedical 
research. However, there is a dire need for increased research into understanding the role 
of exercise in sensory nerve disorders. The lack of understanding in the cellular pathways 
affected by exercise and the molecular changes that lead to benefits is a hindrance to the 
medical community. It is our expectation that certain types of pain may benefit from 
exercise, though different mechanisms driving the development of pain can vary. For 
instance, the benefits of exercise on painful diabetic neuropathy may be influenced by 
concurrent correction of metabolic abnormalities, while nerve damage associate pain may 




exercise and a ketogenic diet are attractive interventions to study fat metabolism as both 











Chapter 2  
Rats bred for low and high running capacity display 
alterations in peripheral tissues and nerves relevant to 












Physical activity and exercise affect a number of metabolic parameters, however, 
not all individuals experience the same benefits from exercise. A multitude of genetic 
factors influence actions of physical activity and exercise 114, and these benefits vary 
among different tissues and organs. Low capacity running (LCR) and high capacity 
(HCR) rats are an experimental rat model designed to examine the underlying 
mechanisms by which high and low aerobic capacity impact susceptibility for a variety of 
chronic disease conditions and lifespan. LCR and HCR rats are commonly used in 
physiological studies designed to understand mechanisms and genetics associated with 
exercise, activity and disease risk 115,116. LCR and HCR rats are outbreed line generated 
from a founder population of male and female N:NIH stock rats based on intrinsic 
aerobic capacity assessed once at each generation by forced speed-ramped treadmill 
running until exhaustion, after which rats are kept in sedentary housing 117. The metabolic 
differences between LCR and HCR rats have shed light on various aspects of activity and 
have proven useful in understanding how metabolic status affects disease. The LCR/HCR 
rat model has identified a genetic basis for the benefits of aerobic capacity and exercise 
on various organ systems including the heart, liver, skeletal muscle, lung, and brain 117-
122. 
There is growing interest about metabolic dysfunction and/or exercise impact the 




is unclear how the genetic differences underlying intrinsic aerobic capacity between LCR 
and HCR rats alter the peripheral nervous system. Previous studies have reported that 
LCR rats have increased fat mass and pro-inflammatory signaling in adipose tissue, as 
well as alterations in cholinergic anti-inflammatory signaling 127,128. Both are known to be 
important in peripheral nerve function and pain. 
Here, we compared a number of pain- and neuropathy-relevant features of the 
peripheral nervous system in female LCR and HCR rats. The selective breeding of the 
LCR and HCR strains results in differences in peripheral nerve sensitivity, cutaneous 
innervation, and composition of the dermis and epidermis. The nature of the differences 
in female LCR rats is consistent with known alterations in the periphery associated with 
poor outcomes in pain and peripheral nerve disease in humans. These findings in LCR 
rats suggest they could serve as novel model to explore the genetic features important in 
pain and abnormal sensory function associated with low aerobic capacity, which is a 





Materials and Methods 
LCR and HCR Rats 
The development of high-/low-capacity rats (HCR/LCR) model displaying high 
and low intrinsic aerobic capacity has been previously described 122,129,130. Female rats 
40-50 weeks of age were dual housed on a 12-h light cycle on a control chow diet [8604 
(14%kcal fat, 54% CHO, 32% protein, 3.9kcal/g), ENVIGO, Madison WI] throughout 
the period of analysis. All animal use was in accordance with NIH guidelines and 
conformed to protocols approved by the University of Kansas Medical Center 
Institutional Animal Care and Use Committee. All rats were examined at the University 
of Michigan prior to their shipment to the University of Kansas Medical Center for 




 Body composition to assess fat mass was measured by MRI using the EchoMRI-
100 (EchoMRI, Houston, TX). Fat mass and lean mass were analytically determined 
immediately prior to exsanguination. Animal weights were measured at the time of 







 At the time of sacrifice, blood was drawn from the chest cavity by cardiac 
puncture and allowed to clot for 25 minutes at room temperature then placed on ice. All 
samples were then spun at 3,000g for 10 min at 4 °C and serum separated and frozen at -
80 °C until subsequent analysis was performed.  Blood serum analysis (total protein, 
albumin, globulin, sodium, potassium, chloride, CO2, calcium, glucose, alkaline 
phosphatase, alanine aminotransferase, bilirubin, phosphorous, blood urea nitrogen, 
creatinine, cholesterol, triglycerides, and insulin) performed by Comparative Clinical 
Pathology Services LLC (Columbia, MO). All rats were removed from their food the 
previous night (12 hours prior to collection).  
 
Behavioral Testing 
 Rats were acclimatized and tested for mechanical and thermal sensitivity as 
previously described 131. Thermal sensitivity latencies from the six applications were used 
to calculate the mean latency per animal and mean latencies were combined to calculate 
group means. Mechanical sensitivity was measured twice (one week apart) 2 weeks prior 
to sacrifice, and the 2 testing days were averaged together to give one total mechanical 






Nerve Conduction Velocity Measurements 
 Rats were anesthetized with an IP injection of 50mg/ml phenobarbital sodium 
salt (Sigma, St. Louis, MO) and motor and sensory nerve conduction velocities were 
recorded. The left sciatic-tibial motor conduction system was stimulated proximally at the 
sciatic notch and distally at the ankle via bipolar electrodes with supramaximal stimuli 
(9.9mA) for 0.2 ms with low and high pass filters of 20 Hz and 10 Hz respectively. The 
latencies of the compound muscle action potentials were recorded via bipolar electrodes 
from the first interosseous muscle of the hind-paw and were measured from the stimulus 
artifact to the onset of the negative M-wave deflection. Motor nerve conduction velocity 
(MNCV) was calculated by subtracting the distal latency from the proximal latency and 
the result was divided into the distance between the stimulating and recording electrode. 
Hind limb sensory nerve conduction velocity (SNCV) was recorded in the digital nerve to 
the second toe by stimulating with a square-wave pulse of 2.4 mA for a duration of 1.0 
ms utilizing a low and high-pass filter of 3Hz and 10Hz respectively. The sensory nerve 
action potential was recorded behind the medial malleolus. Ten responses were averaged 
to obtain the position of the negative peak. The maximal SNCV was calculated from the 
latency to the onset of the initial negative deflection and the distance between stimulating 






Intraepidermal Nerve Fiber (IENF) and Langerhans Cell Measurements  
 Rats were exsanguinated following nerve conduction velocity measurements. 
Cutaneous tissue from the pad of the hind paw were collected, processed, and stained for 
IENFD as previously described 132. IENF density (IENFD) was expressed as number of 
fibers per millimeter of epidermis from a total of 9 images per rat. The combined mean 
IENFD from each rat was used to calculate group means.  
 Langerhans cell measurements were performed using Langerin (E-17) (1:1000; 
Santa Cruz Biotechnology Inc., Santa Cruz, CA) to visualize Langerhans cells. 
Fluorescent images were collected using a Nikon Eclipse 90i microscope using a 10x 
objective. NIH image J software was used to measure each dermal region. Langerhans 
cell density was expressed as number of Langerhans cells per millimeter of epidermis 
from a total of 9 images per rat.  
 
Mast Cell Quantification 
 Footpads were collected and processed as previously described for mast cell 
quantification 133. After imaging a standardized region of interest was placed over all 






Expression of mRNA Encoding Pain Genes 
RNA was extracted and cDNA synthesized as previously described 134. Primer 
sequences for ASIC3, CGRP, COMT, SCN9A, SCN10A, TrkA, TRPA1, TRPV1, and 
TRPV4 were created for rat sequences by Integrated DNA Technologies (Coralvile, IA). 
All reactions were performed in triplicate, and all mRNA levels were normalized to 
GAPDH. ΔΔCT values were used to calculate fold change and relative expression levels.  
 
Statistical Analyses 
Results are presented as means ± SEM. Data were analyzed using unpaired t-test 
and two-factor ANOVA with post hoc comparisons using Fisher’s test of least square 
difference where appropriate. Statistical significance was set at p < 0.05 and analyses 






LCR Rats Have Reduced Aerobic Capacity 
 LCR and HCR rats were examined for running distance, speed, time to 
exhaustion, and energy expenditure on a single occasion at the University of Michigan 
prior to their shipment to the University of Kansas Medical Center. Consistent with this 
model, LCR rats displayed significantly reduced running distance (p<0.0001), running 
speed (p<0.0001), time to exhaustion (p<0.0001), and energy expenditure (p<0.0001) 



















Figure 2.1. Rats classified as high capacity runners display increased abilities in all 
aspects of aerobic testing 
Baseline testing of HCR and LCR rats shows increased (a) distance, (b) speed, (c) 
running time, and (d) energy expenditure in high capacity classified rats as compared to 
low capacity runners. (n=18 for both groups) All data are presented as mean ± SEM 
Cooper et al. 2017 Rats bred for low and high running capacity display alterations in 


















LCR Rats Have More Fat Despite Weighing the Same as HCR Rats 
Female LCR and HCR rats had equal body weights at the time of sacrifice (LCR, 
248.3 ± 4.559; HCR, 246.6 ± 5.725), though the percent of body weight due to fat versus 
lean mass differed between groups (LCR, 8.44% ± 0.6589; HCR, 5.33% ± 0.4328). LCR 
rats had significantly more of their mass distributed as fat (p = 0.0004) and a lesser 
amount due to lean mass (p = 0.003).  
 
LCR Rats Have Lower Mechanical Thresholds 
 Mechanical withdrawal thresholds of the hind paws were significantly reduced in 
LCR rats, as compared to their HCR counterparts (p = 0.008, Figure 2a). There were no 
differences in thermal latencies between LCR and HCR rats (Figure 2b). Conduction 
velocities for both motor and sensory neurons for both LCR and HCR appeared 
comparable with no differences were noted between LCR and HCR rats related to 









Figure 2.2 Mechanical sensitivity is reduced in LCR females  
(a) Mechanical sensitivity test displayed strain specific differences in basal sensitivity of 
LCR rats. (b) Thermal sensitivity testing showed no alterations in withdrawal latency 
between HCR and LCR groups. (c) Basal motor nerve conduction velocities show no 
strain differences between HCR and LCR rats. (d) Basal sensory nerve conduction 
velocities are unaltered between HCR and LCR rats. All data are presented as mean ± 
SEM; n=18 for all groups 
Cooper et al. 2017 Rats bred for low and high running capacity display alterations in 





















LCR Rats have Poor Indicators of Blood Chemistry 
Analyses of a range of blood biomarkers are displayed in Table 1. LCR rats 
display increased potassium (p = 0.005), calcium (p=0.027), alkaline phosphatase (p 
<0.0001), and triglycerides (p = 0.030). All remaining blood serum markers (total 
protein, albumin, globulin, sodium, chloride, total CO2, glucose, alkaline 
aminotransferase, gamma-glutamyltransferase, total bilirubin, phosphorus, blood urea 
nitrogen, creatine, cholesterol, and insulin) were not significantly different between LCR 

















Table 2.1 LCR rats display few variances from HCR rats in serum markers 
Serum blood analysis from 12 hour fasted HCR and LCR rats. LCR rats have statistically 
increased potassium, alkaline phosphatase, calcium, and triglycerides, while no other 
markers were statistically different between LCR and HCR rats.  
Cooper et al. 2017 Rats bred for low and high running capacity display alterations in 















LCR Rats Have a Higher Density of Epidermal Axons 
 Total C-fiber axonal density was increased in the epidermal footpad of LCR rats 
(LCR = 23 fibers/mm2; HCR =19 fibers/mm2, p = 0.047, Figure 3c). The axonal subset of 
C-fibers, which express the tyrosine kinase receptor TrkA, and respond to NGF were 
significantly increased in LCR rats (LCR =14 fibers/mm2; HCR = 11 fibers/mm2, 
p=0.110, Figure 3d). The ratio of TrkA fibers to total PGP-9.5+ fibers was similar 
















Figure 2.3. LCR rats display increased cutaneous innervation 
Merged representative images of double immunofluorescent staining for the pan-neuronal 
markers PGP9.5 and TrkA. a) HCR b) LCR c) LCR animals show increased nerve fiber 
density in the hind paw skin. d) LCR rats display increased peptidergic nerve fiber 
density in the hind paw skin. e) The ratio of TrkA/PGP9.5 shows no difference between 
groups when accounting for total innervation. All data are presented as mean ± SEM; n=6 
for all groups  
Cooper et al. 2017 Rats bred for low and high running capacity display alterations in 
















LCR Rats Have Increased Langerhans Cells and Mast Cells in Cutaneous Tissues 
Quantification of the number of Langerhans cells in the epidermis revealed that 
LCR rats have significantly higher number of Langerhans cells compared to HCR rats (p 
< 0.0001, Figure 4c). In addition, the density of mast cells was increased in the dermis of 


















Figure 2.4. LCR rats display increased mast and langerhans cell density  
Representative images of toluidine blue staining for mast cells. a) HCR b) LCR c) LCR 
rats show increased mast cell density in the hind paw skin. All data are presented as mean 
± SEM; n=5 for all groups. Representative images of immunofluorescent staining for 
Langerin expression (E-17). d) HCR e) LCR f) LCR rats show increased Langerhans cell 
density in the hind paw skin. All data are presented as mean ± SEM; n=6 for all groups 
Cooper et al. 2017 Rats bred for low and high running capacity display alterations in 
















LCR and HCR Have Similar Expression of Pain Genes 
 Analysis of gene expression in the lumbar DRG of LCR and HCR rats revealed 
no significant strain-related differences in the levels of any of the mRNAs examined 






Metabolic syndrome is a medical epidemic in Western society that is 
characterized by a constellation of risk factors including insulin resistance, elevated 
triglycerides, hypertension, and central obesity. The metabolic syndrome is known to 
increase risk for type 2 diabetes and cardiovascular disease 135. Numerous studies have 
linked both prediabetes and metabolic syndrome in animal models and human patients 
with the development of sensor motor polyneuropathy 136. Preclinical modeling of 
polyneuropathy has been challenging and improved animal models encompassing the 
intricacies of human disease are vitally needed 137,138.  
LCR and HCR rats reflect the complex nature of metabolic syndrome through 
extensive breeding for traits known to characterize both a healthy and poor metabolic 
state. The two strains can be divided based on their low and high health risk factors 
determined by their propensity to run greater or shorter distances based on their 
divergence in intrinsic aerobic capacity 117. To date, only male LCR and HCR rats have 
been studied related to peripheral nerve function 115,116, despite a higher incidence of 
chronic pain conditions in female patients 139,140.  
HCR rats displayed increased aerobic function and decreased fat mass consistent 
with prior characterization of the strain, while LCR rats displayed decreased aerobic 
function and increased fat mass 117,141. Female LCR and HCR rats were not different in 
their overall weights. Prior studies have shown clear differences in body weight in female 




examination of aged female rats would have revealed differences in overall body weight. 
In the current study, body weight does not appear to be a confounding factor in our 
observations; differences in fat mass distribution is a more plausible modulator of 
peripheral nerve function rather than overall weight. 
 The present study is the first to examine the serum of female HCR and LCR rats 
across a number of metabolic markers. While potassium levels were statistically 
different, the differences were not physiologically relevant since values less than 6 
mEq/L are considered normal 144. Similarly, calcium levels fall between 9-11 mg/dl, and 
the values observed are not likely physiologically different between LCR and HCR rats 
144. Circulating triglycerides, although significantly higher in LCR rats, were still within 
reported ranges 144. Alkaline phosphatase was also elevated in LCR rats however, levels 
remained below the maximum of reported ranges (maximum of 131 U/L) 144. The serum 
analysis did not identify any differences that explain the anatomical and behavioral 
differences between LCR and HCR rats.  
 
Cutaneous Mechanical Sensitivity 
Female LCR and HCR rats do not demonstrate strain-related baseline differences 
in thermal sensitivity. Previous studies with male LCR and HCR rats demonstrated 
differences in thermal sensitivity between the strains with LCR mice having lower paw 




important clinical indicator of diabetic neuropathy and myopathy 145,146. Here, no 
differences were observed between either sensory or motor nerve conduction velocity 
between LCR and HCR rats.  
Male LCR and HCR rats do not demonstrate baseline mechanical sensitivity 
differences 116. Female LCR and HCR rats demonstrated different baseline responses to 
mechanical withdrawal testing. This suggests, LCR rats have some level of insensitivity 
to mechanical stimuli in comparison to HCR rats. The perception of sensory input is 
likely altered in female LCR rats since the peripheral nervous system remains structurally 
intact with normal nerve conduction velocities. This baseline structural similarity 
between the two strains is important to establish, as the hallmarks of peripheral 
neuropathy are reduced conduction speeds, loss of myelination, and altered sensory 
sensitivity. This lack of structural differences leads us to hypothesize the differences in 
mechanical sensitivity are related to a chronic inflammatory state as a result of the 
metabolic syndrome occurring in LCR rats.  
Models of type 2 diabetes presenting with common signs of metabolic syndrome 
such as increased body weight, fat mass, and blood glucose, often also show systemic 
inflammation and heightened sensitivity 147. Previous work examining the role of 
inflammation in altered sensitivity shows that with profoundly increased inflammation 
there can be an alteration in both thermal and mechanical sensation 148,149. Examination of 
painful areas has revealed that mast cells are a key marker of inflammatory changes in 




Based on this information, we suggest the chronic inflammatory environment present in 
the LCR rat is a state that is primed to drive lower sensory thresholds and allodynia with 
alterations in diet, exercise, or disease. The LCR rat, given its baseline pro-inflammatory 
physiologic state, likely has compensatory central and peripheral modulators of allodynia 
that result in reduced sensitivity and higher thresholds. We hypothesize alterations to 
their physiologic state through diet, injury, or disease state will overwhelm their 
compensatory strategies to mitigate allodynia and promote sensory abnormalities. Hence, 
this rat model lends itself nicely to the study of polygenic features seen in patients with 
neuropathy but have been challenging for inbred or genetic animal models to accurately 
model. 
Genetic differences underlying mechanical and thermal sensitivity have been well 
established by our laboratory and others 132,151. Some have also implicated sex differences 
with the variability in sensory thresholds; despite this, majority of studies generally 
utilize male mice for studies 152,153. Genetic approaches using inbred mouse strains have 
identified a number of mRNAs that are altered in their expression associated with pain 
genetics 151,154. Based on this information we investigated a select number of known 
genes involved with nociceptive transmission in the LCR-HCR models. No strain 
differences were seen in the mRNAs studied that are known to have a role in nociception, 
which suggests at least in the expression of the genes studied, there is no underlying 





Intraepidermal Nerve Fiber Density 
IENFD is a valuable tool to visualize sensory innervation of the epidermis by 
small unmyelinated C-fibers 155,156. These C-fibers are responsible for transmitting 
mechanical, thermal, and noxious stimuli from the epidermis and are impacted by the 
metabolic status in animals and humans 157. Reductions in IENFD correlate with small 
fiber damage and sensory neuropathies 158,159. Previous work by our group and others has 
displayed that IENFD is altered by changes in diet and exercise 17,136,160. Here, female 
LCR rats demonstrated a significant increase in the density of PGP-9.5+ intraepidermal 
nerve fibers compared to HCR rats. It should be reminded that alterations between groups 
are not due to physical activity effects on the skin, as these rats are not exercised after 
initial baseline examination. The LCR rats also had increased number of fibers 
expressing TrkA, the high affinity receptor for NGF. TrkA-positive axons play an 
important role in pain transmission 161,162. However, the overall percentage of TrkA fibers 
was similar between groups. Studies have established allodynia and reduced mechanical 
thresholds are associated with increased TrkA fibers 17,163,164. This increase in IENF and 
increase in TrkA+ fiber density may predict that LCR rats display a greater response to 
evoked allodynia and are at risk for longer duration of heightened sensitivity. 
Langerhans Cells 
Langerhans cells are transient dendritic antigen-presenting cells located in the 
epidermis. They play a critical role in the epidermal immune response and are also found 




Langerhans cells function using mechanisms similar to macrophages and respond to 
similar signaling agents such as inflammatory cytokines and calcitonin gene-related 
peptide 166,167. These cells are found in close proximity to regulatory T cells and effector 
memory T cells, again highlighting a strong antigen-response role in the epidermis 168. 
Previous studies have demonstrated that Langerhans cells density correlates strongly with 
intraepidermal nerve fiber density and changes in mechanical sensitivity associated with 
allodynia 169,170. In mice depleted of Langerhans cells using diphtheria toxin, mechanical 
sensitivity increased as a result of the loss of Langerhans cells 169. Similar to this result, 
female HCR rats in this study display decreased epidermal Langerhans cells as compared 
to their LCR counterparts and decreased mechanical sensitivity thresholds.  
 
Mast Cells 
Similar to Langerhans cells, mast cells play a significant role in innate and 
adaptive immunity; however, they modulate neuropeptides involved in sensory 
processing and signaling 171,172. Mast cells have a well-established neuroimmune 
response through the reaction to inflammatory signaling and subsequent synthesis and 
release of neurotrophins highlighting an important molecular marker of peripheral nerve 
inflammatory response 173,174. Together these neurophysiological and molecular markers 
indicate peripheral nerve function and health status. Mast cell degranulation releases a 
number of molecules important in nociceptive signaling and degranulation is known to be 




numbers of mast cells in epidermis and dermis of the hind paw compared to female HCR. 
Again, this may be reflective of their inflammatory state, which could contribute to the 
development of sensation abnormalities. 
 
In conclusion, female LCR and HCR rats demonstrated differences in mechanical, 
but not thermal sensitivity. The strains did not have altered gene expression for common 
markers, ion channels, and receptors of nociceptors. Female HCR and LCR rats had 
similar nerve conduction velocities and proportion of intraepidermal nerve fiber types in 
the hind paw. Female LCR rats show increased inflammatory cells within the peripheral 
nervous system that could increase allodynia in diseased states. In order to understand sex 
differences in allodynia and analgesia, female HCR and LCR were used to determine 
baseline characteristics of the peripheral nervous system in preparation for future studies 
















Chapter 3  
Exercise alters metabolic parameters and inflammation to 












 Diabetes is a rising epidemic throughout the United States and the world. As of 
2014, 29.1 million people, or 9.3% of the population have diabetes 176. A larger group 
emerging in the U.S. however, is patients with prediabetes, as 86 million adults are pre-
diabetic and 9 out of 10 of these individuals are unaware that they have prediabetes 176. A 
growing body of literature is discovering that patients with prediabetes begin to 
experience the onset of neuropathy that was traditionally thought to be a development of 
long-term diabetes 17,177,178. While the neuropathy associated with prediabetes is less 
severe than neuropathy seen in overt diabetes patients 179, the painful symptoms are still a 
devastating complication for these patients.  
 A prominent model used to study painful neuropathy in diabetes is to utilize a 
high-fat diet to induce mechanical allodynia 17,180-182. Our previous studies have 
demonstrated that exercise reduces, but does not fully restore diet-induced metabolic 
abnormalities 17. Physical activity provides great benefits to medical and pharmaceutical 
treatments for individuals with neuropathy 183, and in many instances varying forms and 
intensities of exercise has been prescribed to alleviate the symptoms of a growing number 
of different types of neuropathic pain 31,32,36,37,39,184. However, the mechanisms by which 
exercise exerts its beneficial actions remain poorly understood.  
 Poor diet and lifestyle are common factors connected with the development of 
both pre- and overt diabetes 185. These often lead to an increase in fat mass, an increase in 




affecting numerous tissues 186-189. Mitochondrial alterations can affect metabolism in 
numerous tissues, though this topic has often been overlooked in the peripheral nervous 
tissues 190-193. Numerous noxious pain sensors are activated/sensitized by inflammatory 
agents 149,194-197, many of which can be deactivated through the decrease of these 
inflammatory agents, possibly by exercise, which has a strong history of anti-
inflammatory signaling even independent of a decrease in fat mass or weight 198,199. 
 Transient receptor potential vanilloid 1 (TRPV1) is one of the most prominently 
studied transient receptor potential (TRP) channels, and is often examined in its role of 
sensing chemical agents associated with inflammation and transmitting a noxious 
stimulus signal through the sensory nervous system 200,201. TRPV1 translocation may 
require the binding of a synaptosomal protein complex involving synaptosomal-
associated protein 23 kDa (SNAP23) & synaptosomal associated protein 25 kDa 
(SNAP25) based on the evidence that SNAP25 is implicated in the translocation of 
phosphorylated TRPV1 to the surface of the cell membrane 202. During translocation and 
insertion into the membrane, TRPV1 activating signals can open another TRP channel, 
the transient receptor potential cation channel member A1 (TRPA1). This ability to 
activate the TRPA1 channel, known to drive mechanical sensitization, establishes a direct 
link between TRPV1 and our observed phenotype of mechanical allodynia from a high-
fat diet 203.  
 In the current study, our results reveal that a high-fat diet alters molecular 




periphery nerves. Effects of exercise have select actions, which is surprising in context of 
the many positive benefits on metabolic factors known to improve with exercise, and 
many of which would be predicted to influence pain pathways. However, we show that 
the alterations from exercise occur independent of alterations in body weight, fat mass, 
and traditional mitochondrial and metabolic signals, suggesting that exercise benefits 







Seven-week-old male C57/BL6 #027 mice were purchased from Charles River 
(Wilmington, Mass) and maintained on a 12:12h light/dark cycle in the research support 
facility at the University of Kansas Medical Center. All mice were given ad libitum 
access to food and water and were fed either a chow diet (8604; Envigo, Madison 
Wisconsin; 14% kcals from fat, 32% protein, and 54% carbohydrate) or a high-fat diet 
(07011; Envigo; 54% kcals from vegetable shortening (hydrogenated) and corn oil fat, 
21% protein and 24% carbohydrate). All mice were fed the standard diet through all 
baseline testing. After baseline behavioral testing was complete, mice were separated and 
the groups were given different diets. All animal use was in accordance with NIH 
guidelines and conformed to the principles specified in a protocol approved by the 
University of Kansas Medical Center Institutional Animal Care and Use Committee.  
 
Voluntary Exercise 
Following baseline testing, mice were separated into either sedentary controls or 
exercise groups. Exercise mice were housed individually in cages designed to hold 
stainless-steel running wheels (Mini Mitter; Bend, OR) and given free access to run 24/7. 
VitalView (Mini Mitter) software measured total wheel revolutions for each mouse 




suggestion of veterinary staff in the animal facility. Mice were given access to diet and 
running wheels simultaneously following baseline behavior testing and subsequent group 
assignment. Treatment groups are identified throughout the study as: chow-fed sedentary 
(CF-Sed), chow-fed exercise (CF-Ex), high-fat diet sedentary (HF-Sed), and high-fat diet 
exercise (HF-Ex).  
 
Blood Measures 
Animal weight and blood glucose (glucose diagnostic reagents; Sigma, St. Louis, 
MO) was measured weekly. At sacrifice, blood was drawn from the chest cavity and 
allowed to clot for 30 min on ice, then spun at 3,000g for 30 min at 4 °C and serum 
drawn off and frozen at -80 °C until bradykinin and β-hydroxybutyrate were analyzed 
from this sample. All mice were fasted three hours prior to blood collection for all blood 
chemistry panels.  
 
Mechanical Sensitivity 
Mice were allowed to acclimate to the testing equipment in two separate sessions 
prior to the initial baseline-testing day. Before each behavior test, mice were allowed to 
acclimate to the sound cushioned behavior testing room for 30 minutes followed by a 30-
minute acclimation to the testing equipment. Mice were placed in individual clear plastic 




were applied perpendicularly to the plantar surface of the hind paw until the filament 
bent. Testing began with the 0.6 g filament. If the mice withdrew their paw, it was 
counted as a positive withdrawal and the next lowest filament was applied. If the animal 
did not respond, the next larger filament was applied. Filaments were applied until there 
was an initial change in response followed by four additional filament applications. The 
50% withdrawal threshold was calculated using the formula from the up-down method 
previously described 204.  
 
Body composition analysis  
Body composition to assess water density and fat mass was measured by MRI 
using the EchoMRI-100 (EchoMRI, Houston, TX). Fat mass and lean mass were 
analytically determined by the instrument. Body composition was determined 
immediately before sacrifice at completion of 12 weeks of diet and exercise.  
 
Metabolic Testing  
A metabolic monitoring system (Promethion, Sable Systems Int., Las Vegas, NV) 
measuring oxygen consumption, carbon dioxide production, and a multi-dimensional 
infrared beam break system was employed to assess the total energy expenditure (TEE) 
and respiratory quotient (RQ) over a 48-hr period, 10 weeks after implementation of diet 




acclimate to the chamber environment for two days prior to data collection. Data were 
analyzed as two 12-hour cycle averages (12 hours ambient light [07:00-19:00] and 12 
hours of dark [19:00-07:00]) and were calculated per animal; these light and dark 
averages were then used to calculate group means. 
 
mRNA Analysis 
 RNA was extracted from DRG using TRI Reagent (Sigma) and RNeasy Mini Kit 
(Qiagen, Valencia, CA, USA). Sample concentration and purity were determined using a 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Complementary DNA 
(cDNA) was synthesized from total RNA using the iScript cDNA synthesis kit (Bio-
Rad). qRT-PCR was performed using Sso Advanced Supermix Kit (Bio-Rad). A custom 
PCR plate was purchased from Bio-Rad to analyze the mRNAs for tumor necrosis factor 
(TNF-α), Interleukin 1 Beta (IL-1β), Interleukin 6 (IL-6), mitogen-activated protein 
kinase 14 (p38), mitogen-activated protein kinase 8 (JNK), nerve growth factor (NGF), 
synaptosomal-associated protein, 23kDa (SNAP23), syntaxin binding protein 4 
(STXBP4), vesicle-associated membrane protein 2 (VAMP2), therefore these primer 
sequences are not available to publish. All reactions were performed in triplicate, and all 
mRNA levels were normalized to GAPDH. ΔΔCT values were used to calculate fold 





Western Blot Analysis  
At the time of sacrifice, lumbar DRG 4-6 were flash frozen in liquid nitrogen and 
stored at -80 °C until processing. All 6 DRGs were sonicated in 100µl of ice-cold cell 
extraction buffer (Invitrogen, Carlsbad, CA) containing 55.5 µl/ml protease inhibitor 
cocktail (Sigma, St. Louis, MO) 200 mM Na3VO4 and 200 mMNaF and vortexed for 3-5 
seconds every 10 min for 70 min while kept on ice for protein extraction. Following 
centrifugation at 7000 rpm at 4 °C for 15 min the supernatant was removed and the 
protein concentration of the supernatant was determined by Bradford assay (Bio-Rad, 
Hercules, CA) performed in triplicate. Samples were diluted in HES buffer (20 mmol/1 
HEPES, 1 mmol/1 EDTA, 200 mol/1 sucrose, pH 7.4) and 5 x Laemmli buffer containing 
100 mmol/1 dithiothreitol (Thermo Scientific) based on protein concentration to generate 
samples containing the same concentration of protein for analysis by Tris-glycine gels. 
Samples were heated in a boiling bath for 5 min. and stored at -20 °C until use. A second 
set of identical samples were made but not boiled for analysis of oxidative 
phosphorylation (OXPHOS) of electron transport complexes. Equal amounts of protein 
(35 µg) were loaded and separated on a 4-15% gradient Tris-glycine gel (Bio-Rad; 
20mA/gel, 60 min) and then transferred to a nitrocellulose membrane (200 mA, 80 min, 4 
°C). Membranes were blocked for 1-2 hrs at room temperature in Tris-buffered saline, 
0.1% Tween 20 (TBST), and 5% nonfat dry milk or 1%BSA, followed by an overnight 
incubation with appropriate primary antibodies. Primary antibodies were diluted in TBST 
with 1% nonfat dry milk or 1-5% BSA of concentrations as listed at the end of this 




temperature in TBST 1% nonfat dry milk supplemented with an appropriate HRP-
conjugated secondary antibody at a concentration of 1: 10,000. Blots were then washed 
twice with TBST and once with TBS. Blots were then visualized using SuperSignal West 
Femto Enhanced Chemiluminescence reagent (Thermo Scientific, Rockford, IL). 
Membranes were exposed either to X-ray film or on a ChemiDoc XRS (Bio-Rad, 
Hercules, CA) and analyzed using Image J densitometry (for X-Ray film) or Image Lab 
5.2 software (for ChemiDoc XRS) (Bio-Rad, Hercules, CA). Blots were then stripped and 
re-probed for β–actin or another target antibody. Blots were stripped for 15 min. at 55 °C 
in buffer containing 62.5 mmol/1 Tris-HCL, 2% SDSS, and 100 mmol/1 2-
mercaptoethanol. Antibodies include Anti-Total OXPHOS (1:333, Abcam, Cambridge, 
MA); Anti-p38 MAPK and Anti-Phospho-p38 MAPK (1:1000, Cell Signaling, Danvers, 
MA); Anti-PPAR-α (1:500. Abcam, Cambridge, MA); Anti-Snap23 (1:1000, Abcam, 
Cambridge, MA); Anti-Snap25 (1:1000, Abcam, Cambridge, MA); and Anti-β-Actin 
(1:2500, Abcam, Cambridge, MA).  
 
Statistical Analyses 
Results are presented as means ± SEM. Data was analyzed using a two-factor 
ANOVA with post hoc comparisons analyzed using Fisher’s test of least square 
difference where appropriate. Statistical significance was set at P < 0.05 and analyses 





By 6 weeks, both high-fat fed groups had decreases in withdrawal thresholds 
compared to chow-fed exercised and sedentary (HF-Sed, p=0.072; HF-Ex, p=0.068) 
mice, although thresholds of high-fat fed mice were only statistically significantly 
decreased relative to chow-fed exercised mice (HF-Ex, p = 0.049; HF-Sed, p = 0.051). At 
the conclusion of the study, high-fat sedentary mice maintained decreased thresholds 
relative to the chow-fed sedentary controls (p = 0.018), whereas thresholds of high fat 
exercised mice were rescued and fell between chow sedentary mice and high fat 


















Figure 3.1: Mechanical thresholds were reduced in both HF-Ex and HF-Sed mice 
compared to control mice after 6 weeks of a high-fat diet. HF-Ex mice return to baseline 
levels at 12 weeks of physical activity. (n=8 for all groups) All data presented as mean ± 
SEM *: CF-Sed vs HF-Sed #: CF-Ex vs HF-Sed ^: HF-Sed vs HF-Ex °: CF-Ex vs HF-
Ex.  
Cooper et al. 2017 Modulation of diet-induced mechanical allodynia by metabolic 

























Figure 3.2: (A) A high-fat diet causes weight gain in both HF-Sed and HF-Ex mice 
compared to their standard diet controls (n=8 for all groups). (B) A high-fat diet slightly 
increases blood glucose levels in both exercised and sedentary mice, though 
hyperglycemia does not develop in either cohort. (C) A high-fat diet causes fat mass 
gains in both HF-Sed and HF-Ex mice compared to their standard controls (n=4 for all 
groups).(D) High-fat sedentary mice show increased ketones in the blood compared to 
both chow-fed and high-fat fed mice. A main effect of exercise in reducing the level of 
blood ketones is present (p <0.05). All data presented as mean ± SEM. *:CF-Sed vs HF-
Sed #: CF-Ex vs HF-Sed +: CF-Sed vs HF-Ex ^: HF-Sed vs HF-Ex °: CF-Ex vs HF-Ex 
Cooper et al. 2017 Modulation of diet-induced mechanical allodynia by metabolic 


















 High-fat sedentary and high-fat exercised mice gained more weight compared to 
both chow-fed groups (Fig. 2a). Additionally, measurements of body weight due to 
changes in fat vs. lean mass revealed a main effect of diet on fat mass (p <0.0001, Fig. 
2b). Both high-fat sedentary and high-fat exercise mice gained significantly more fat 
mass compared to chow-fed groups (CF-Sed vs. HF-Sed, p = 0.001; CF-Sed vs. HF-Ex, p 
= 0.025; CF-Ex vs. HF-Sed, p = 0.0002; CF-Ex vs. HF-Ex, p = 0.005, Fig. 2b). No 
alterations in lean mass were noted between any groups.  
 High-fat sedentary and high-fat fed exercised mice had elevated blood glucose 
levels compared to chow-fed mice two weeks after diet and exercise initiation (Fig. 2c). 
Both high-fat diet groups’ blood glucose levels remained below 250 mg/dl.  
Serum bradykinin was not altered by diet or exercise when compared to all groups 
or by main effects. Serum β–hydroxybutyrate displayed a main effect of exercise (p = 
0.021) and was significantly elevated in high fat sedentary mice compared to both 
exercised groups (HF-Sed vs. CF-Ex, p = 0.016; HF-Sed vs. HF-Ex, p = 0.0119), though 












Figure 3.3: (A) Dark cycle respiratory quotient (RQ) has a main effect of diet as seen 
with high-fat fed mice as compared to chow-fed controls (p < 0.0001). (B) A decreased 
RQ corresponding with diet is still present (p < 0.0001) during light cycle hours though 
the difference in RQ is less significant. (C) Light cycle total energy expenditure (TEE) is 
unaltered by diet or exercise (D) Dark cycle TEE is increased with exercise in chow-fed 
mice but not high-fat fed mice as compared to chow-fed controls. A high-fat diet did 
increase TEE in sedentary mice as compared to their chow fed counterpart. (n=4 for all 
groups) All data presented as mean ± SEM. 
Cooper et al. 2017 Modulation of diet-induced mechanical allodynia by metabolic 




















Regardless of exercise training, mice on a high-fat diet had a reduced RQ (dark 
cycle p<0.0001; light cycle p < 0.0001); while mice fed a normal chow diet had an RQ of 
~0.8 (Figs. 3a, b). Analysis of fuel source utilization in relation to dark-light cycles 
displayed significant differences (CF-Sed vs. HF-Sed, p <0.0001; CF-Sed vs. HF-Ex, p = 
0.0002; CF-Ex vs. HF-Sed, p <0.0001; CF-Ex vs. HF-Ex, p <0.0001). The light cycle 
showed similar albeit less significant alterations (CF-Sed vs. HF-Sed, p = 0.001; CF-Sed 
vs. HF-Ex, p = 0.0013; CF-Ex vs. HF-Sed, p = 0.0003; CF-Ex vs. HF-Ex, p = 0.0003).  
 Analysis of energy expenditure was divided into 12-hour dark and light cycle 
quantifications and revealed no differences between any groups (Fig. 3c). Dark cycle 
analysis displays increased energy expenditure of both high-fat sedentary (p = 0.0120) 
and chow-fed exercised mice (p = 0.0254) compared to chow-fed sedentary mice (Fig. 
3d).  
The expression of mRNA encoding TFAM, DGKB, BDH1, HSP60 and HIF1-α 
was unaltered by diet or exercise. HSP70 mRNA levels were increased by exercise 
compared to sedentary mice (CF-Sed vs. HF-Ex, p = 0.014; HF-Sed vs. CF-Ex, p = 
0.014; HF-Sed vs. HF-Ex p = 0.003, Fig. 4a). TrkA mRNA was reduced in high fat fed 
exercised mice compared to chow-fed sedentary mice (p = 0.024). Diet or exercise did 
not alter the expression of mRNAs encoding CGRP and NGF (Fig. 4b). 
 Exercise significantly decreased IL-1β (p = 0.011) and IL-6 (p = 0.032) levels in 
high fat-fed exercised mice compared to high-fat sedentary mice. IL-6 levels were 




fat sedentary mice (p = 0.002, Fig. 4c). TNF-α was not significantly reduced in high-fat 
fed exercised mice relative to high fat sedentary mice (p = 0.053). In addition, p38 was 
decreased in high-fat fed exercised mice relative to chow-fed sedentary mice (p = 0.032) 
and high-fat sedentary mice (p = 0.0376). JNK was significantly decreased in high-fat fed 
exercised mice relative to high fat sedentary mice (p = 0.039).  
 TRPV1 mRNA expression was increased in chow-fed exercised mice relative to 
chow-fed sedentary (p = 0.037) and high-fat exercised mice (p = 0.026, Fig. 4d). 
AKAP150 was significantly increased relative to chow-fed sedentary (p = 0.030) and 
high-fat exercised mice (p = 0.012). TRPA1 was increased in high-fat fed sedentary mice 
compared to chow-fed sedentary (p = 0.049) and high-fat exercised mice (p = 0.040). 
mRNAs encoding SNAP23 (p = 0.035), SNAP25 (p = 0.009), and Stxbp4 (p = 0.033) 
were increased in high-fat fed sedentary mice compared to high-fat fed exercised mice. 
VAMP2 mRNA was slightly decreased in high-fat fed exercised mice compared to high-
fat sedentary (p = 0.084). VAMP2 was statistically different in high-fat exercised mice 









Figure 3.4: (A) Exercise increases gene expression of HSP70, but not HSP60, relative to 
sedentary controls. (B) Exercise reduces gene expression of inflammatory cytokines 
(TNF- α, IL-1β, IL-6, p38, and JNK) induced with a high-fat diet and sedentary 
environment. (C) Traditional pain related genes are unaltered by diet or exercise, except 
TrkA, which is reduced in HF-Ex mice relative to CF-Sed controls. (D) Exercise reduces 
gene expression of synaptosomal complex components (SNAP23, SNAP25, STXBP4) in 
high-fat diet fed mice. (E) A high-fat diet increases gene expression of AKAP150 (the 
kinase for TRPV1) and TRPA1 relative to chow-fed controls, and exercise reduces gene 
expression back to levels not different from chow fed controls. (n=4 for all groups) All 
data presented as mean ± SEM. 
Cooper et al. 2017 Modulation of diet-induced mechanical allodynia by metabolic 

















Western blot analyses revealed no changes in phosphorylation of p38 protein in 
the DRG due to diet or exercise. There were no significant alterations in any of the 
electron complexes analyzed between groups (Fig. 5a, 5b, 5c, 5d). PGC1-α, 
phosphorylated and total AMPK protein levels were not different across groups. Analysis 
of SNAP23 and SNAP25 protein levels also revealed no differences in response to diet or 
exercise.  
Analysis of PPAR-α protein expression revealed increases in high-fat sedentary 
and high-fat exercised mice compared to chow-fed sedentary and chow-fed exercised 
mice (HF-Sed vs. CF-Sed, p = 0.0188; HF-Sed vs. CF-Ex p = 0.0184; HF-Ex vs. CF-Sed 















Figure 3.5: (A, B, C, D) Electron complex’s II, III, IV, and V are unaltered by either diet 
or exercise in the DRG of mice (E) The main effect of a high-fat diet increases PPAR-α 
in both exercise and sedentary mice as compared to their chow-fed counterparts (p < 
0.001). (CF-Sed n=6, CF-Ex n=5, HF-Sed n=7, HF-Ex n=8) All data presented as mean ± 
SEM. 
Cooper et al. 2017 Modulation of diet-induced mechanical allodynia by metabolic 


















 Our results demonstrate that mice fed a high-fat diet develop mechanical 
allodynia 17,180. Mice with access to running wheels have a slow attenuation of 
mechanical allodynia after 6 weeks of exercise. We investigated potential molecular 
mediators that may explain how exercise benefits allodynia caused by a high-fat diet and 
revealed that exercise can correct sensory impairments without inducing changes in 
several key metabolic parameters. 
In previous studies using high-fat diets, sedentary mice increase fat storage and 
weight gain, while exercised mice fail to gain weight and increase fat mass similar to 
sedentary mice 205. Exercised mice fed a high-fat diet gained weight similar to high-fat 
fed sedentary mice. It is plausible to suggest these metabolic changes are due to exercise-
induced increases in muscle mass as opposed to fat. Our results suggest changes other 
than fat mass reduction may be important in influencing allodynia based on the result that 
high-fat fed exercised mice did not differ in lean and fat mass compared to sedentary 
high-fat fed mice. 
Since fat mass and weight changes may not explain the benefits associated with 
exercise, differences in utilization of fat as an energy source could be important. All our 
metabolic measures were obtained in cages where mice did not have access to running 
wheels to avoid acute metabolic changes associated with exercise. High-fat diets induce 
whole body lipid oxidation as evidenced by respiratory quotients (RQ) that approach a 




utilize fats as a primary fuel source, suggesting that exercise does not lead to greater 
utilization of fat as an energy source. This is supported by our findings that sedentary 
high-fat fed mice had a greater resting energy expenditure compared to high-fat exercised 
mice. The sedentary high-fat fed mice had the highest fat pad mass, the greatest weight 
gains, and burned the most energy, indicating resting energy output may not be a key 
factor in the amount and utilization of fat related to allodynia. One caveat is that the 
current study performed the calorimetric analysis in caging without running wheels, 
which could be argued to dampen the effects of 10 prior weeks of training. 
We found increased blood levels of β-hydroxybutyrate in sedentary high-fat fed 
mice and that exercise significantly reduced β-hydroxybutyrate levels. Normally when 
utilizing fat as a key fuel source, ketone levels are elevated 207. Exercised high-fat fed 
mice may process fat more efficiently, leading to a decrease in ketones. We analyzed 
PPAR-α, a fatty acid-activated transcription factor increased during ketogenesis208. While 
PPAR-α protein levels were increased by the high-fat diet, exercise was unable restore 
elevated levels of PPAR-α in the DRG. The role of PPAR-α in DRG neurons is complex, 
as it has been shown to play a role in both analgesia and pain 209. 
Our results suggest the benefits of exercise are not mediated via increased fat 
metabolism alone, since high fat exercised mice have increased fat pad mass and burn 
fats as a primary fuel source, while expending less resting energy than high-fat fed 
sedentary mice. Exercised mice fed a high-fat diet displayed improved ketone processing 




mediators associated with inflammation. This suggests that exercise exerts benefits by 
affecting inflammatory pathways that influence the peripheral nervous system compared 
to the whole-body fat storage and utilization.  
The reduction of inflammatory mRNAs (TNF-α, IL-1β, IL-6, p38, JNK) in high-
fat exercised mice as compared to sedentary high-fat mice is consistent with exercise’s 
anti-inflammatory role. Based on the exercise-induced changes in inflammatory gene 
expression, we hypothesized that this could lead to changes in TRP ion channels 
associated with pain 210. Our results revealed that TRPV1 mRNA was unaltered by diet or 
exercise. A kinase involved in the translocation and insertion of TRPV1 into membranes, 
AKAP150, was significantly decreased in high-fat exercised mice. Modification of 
TRPV1 trafficking and translocation are consistent with alterations in the synaptosomal 
complex. SNAP23/25, STXBP4, and VAMP2 were all decreased in high-fat diet 
exercised mice. These results point to a possible mechanism related to TRP channel 
trafficking and membrane insertion. 
TRPA1 was also examined as it often co-localizes with TRPV1 and is co-
activated through TRPV1 signaling 203,211. TRPA1 mRNA was elevated in high-fat 
sedentary mice and decreased in high-fat exercised mice. Changes in TRPA1 levels 
provide a strong link to the mechanical allodynia that occurs in response to a high-fat 
diet, and also suggests that future studies of both TRPV1 and TRPA1 are needed to fully 











Chapter 4  
 Positive Impacts of Ketogenic Diet on Metabolic Syndrome-











Obesity and metabolic syndrome are a growing international epidemic, and have 
been strongly linked to the development of chronic pain 212. The consumption of high fats 
and carbohydrates leads to metabolic alterations and changes in sensory function in mice 
similar to changes that occur in human patients, which include obesity, elevated blood 
glucose, insulin resistance, and mechanical allodynia 17,180,182. Physical activity and 
exercise can improve many of these symptoms, including reversing mechanical allodynia 
induced by a high fat diet 17; however, the mechanisms by which exercise leads to 
alterations in metabolic and sensory nerve function is poorly understood. The present 
study aimed to examine if a ketogenic diet has similar beneficial effects on obesity, 
chronic pain, and sensory nerve function as compared to exercise intervention.  
 High fat, low carbohydrate diets that lead to increased ketone production 
popularly named ‘ketogenic’ diets are a rapidly emerging intervention for a wide array of 
clinical diseases 103,213,214. Historically, ketogenic diets were first utilized in the treatment 
of epilepsy after it was noted that patients who fasted had reduced seizure occurrence 214. 
Recently, ketogenic diet intervention has been tested as a treatment for several nervous 
system diseases, including glioblastoma, Alzheimer’s disease, amyotrophic lateral 
sclerosis, traumatic brain injuries, and autism 87-95. Relevant to peripheral nerve function, 
to date, a limited number of studies have examined how a ketogenic diet impacts 




 Previous research has demonstrated that exercise and a high fat diet create 
distinctive metabolic phenotypes both systemically and in the peripheral nervous system 
215. Both exercise and ketogenic diets are attractive approaches for therapeutic 
intervention to treat obesity and metabolic syndrome as both increase fat oxidation 112,113. 
Additionally, both exercise and ketogenic diet can stimulate anti-inflammatory signaling 
cascades and reduce chronic inflammation that occurs in response to a high fat diet 100. A 
dietary intervention may also be a more attractive clinical intervention, as numerous 
patients are often unable or unwilling to perform physical activity.  
 Here, we examine several parameters of peripheral nervous system function from 
mice fed a ketogenic diet. We have previously reported that mice fed a high fat and 
carbohydrate-rich diet develop symptoms related to painful peripheral neuropathy in 
prediabetes including mechanical allodynia 17,180,215. In the current study, we provide 
evidence that despite consuming very high levels of fat, mice fed a ketogenic diet fail to 
develop mechanical allodynia, opposed to mice fed a high fat diet. Additionally, a 
ketogenic diet can reverse high fat diet-induced mechanical allodynia independent of 
other obesity-related measures. Together, these results suggest that a ketogenic diet may 
be an effective intervention for prediabetic and diabetic peripheral neuropathy, and may 







Diet and Mice 
Seven-week-old male C57/BL6 #027 mice were purchased from Charles River 
(Wilmington, Mass) and maintained on a 12:12h light/dark cycle in the research support 
facility at the University of Kansas Medical Center in corn cob bedded, forced air cages. 
All mice were given ad libitum access to food and water and were fed either a standard 
chow diet (8604; Envigo, Madison Wisconsin; 14% kcals from fat, 32% protein, and 54% 
carbohydrate), a high fat diet (07011; Envigo; 54% kcals from vegetable shortening 
(hydrogenated) and corn oil fat, 21% protein and 24% carbohydrate), or a ketogenic diet 
(96355; Envigo; 90.5% kcals from vegetable shortening (hydrogenated) and corn oil fat, 
9.2% protein, and 0.3% carbohydrate). Standard diet energy was calculated as previously 
described 17. 
Two cohorts of mice were utilized to examine the effects of dietary and exercise 
interventions. The first cohort was fed a control diet through all baseline testing. After 
baseline behavioral testing was complete, mice were separated to provide all groups with 
equal baseline values for behavioral and metabolic measures; and the groups were given 
different diets and exercise intervention (control fed-sedentary, high fat-sedentary, high 
fat-exercise, or ketogenic). The second cohort henceforth referred to as ‘obesity 
interventions’ mice were all fed a high fat diet for eight weeks and through baseline 
testing. After baseline behavioral testing (at week 8), mice were separated into similar 




ketogenic). All mice were 8 weeks of age at the start of diet and exercise. A timeline of 
diet and exercise intervention for both cohorts is displayed in Figure 1. All studies were 
in accordance with NIH guidelines and conformed to protocols approved by the 























Figure 4.1: a) All mice remained on a control diet until baseline testing was completed, 
then mice were changed to experimental diets and exercise for 12 weeks. b) Obesity 
Interventions cohort timeline: all mice remained on a high fat diet for 8 weeks, at which 
point baseline testing was completed, groups where then formed and mice were changed 



















Ketogenic-fed and obesity intervention groups of mice underwent assessments for 
weight and blood glucose (glucose diagnostic reagents; Sigma, St. Louis, MO) weekly 
after a 3 hour fast 17. Additionally, at the time of sacrifice following a 3 hour fast, blood 
was drawn from the chest cavity and allowed to clot for 30 min on ice, spun at 3,000g for 
30 min at 4 °C and serum drawn off and frozen at -80°C until insulin was analyzed by 
ELISA (Alpco; Salem, NH). Blood ketones (β-Ketone blood test strips; Precision Xtra; 
Abbott Laboratories; Chicago, IL) were measured at baseline, week 1, 4, 8, and at 
sacrifice following a 3 hour fast.  
After 4 weeks, an intraperitoneal glucose tolerance test (IPGTT) was performed 
after a 6 hour fast. Animals were given 1g glucose/kg body weight. Blood glucose levels 
were measured via tail clip immediately before glucose injection, and 15, 30, 60, and 120 
minutes thereafter. 
Body Composition 
Body composition to assess fat mass was measured using the EchoMRI-100 
(EchoMRI, Houston, TX). The body composition of the first cohort of mice was 
determined immediately before sacrifice. Mice in the obesity intervention groups had 





 Mechanical sensitivity was assessed using Von Frey monofilaments as previously 
described 17. Thermal thresholds were assessed by placing mice in individual clear plastic 
cages on a Hargreaves’s apparatus and a 4.0 V radiant heat source was applied three 
times to the hind paw as previously described 17. Sensory behavioral assessments were 
carried out at baseline and biweekly for all mice for 12 weeks. Cohort 1 mice (dietary 
intervention) were examined for both mechanical and thermal sensitivity, while mice in 
the obesity intervention groups were only examined for mechanical sensitivity. 
RNAseq 
Total RNA for the first cohort of mice was extracted with TruSeq Stranded 
mRNA Library Prep kit (Illumina, CA). Six biological replicates were used for each 
dietary and exercise intervention group, for a total of 24 samples. Pair-end sequencing 
was performed using the Illumina platform with read length of 100 bp and an insert size 
of 160 bp. FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) was used 
to access sequence quality, with manual inspection of the results before proceeding to 
subsequent steps. The raw gene count data was obtained using RSEM216 using the default 
parameters. Within RSEM, we used the bowtie2217 as mapping tool and the mouse mm10 
genome assembly as the reference genome.  
The Bioconductor package “edgeR”218 was used for preprocessing the raw gene 
count data. Gene count data were normalized by library size and genes with non/low 




in at least 2 out of the 24 samples were retained, resulting in a total of ~16,000 genes that 
were considered for subsequent statistical analyses.  
Transcriptional changes in pain-associated genes were then compared across the 
different dietary and exercise intervention groups. First, a list of 25 pain-associated genes 
was manually selected. The normalized and log-transformed expression of those genes 
were then used in principal component analysis (PCA) to gain insight into the potential 
drivers of variation in the expression of pain-associated genes. To visualize the PCA 
results, scatterplots of the first, second, and third principal components, which 
collectively explained nearly 75% of the variation across the 25 selected pain-associated, 
were generated. Finally, to examine the association between the top principal components 
and dietary and exercise intervention group, a series of ANOVA models were fit that 
modeled the each of top 3 principal components as the response, against the different 
dietary and exercise intervention groups.   For these analyses, statistical significance was 
defined as p <0.05. 
 
Statistical Analysis 
 All data is presented as mean ± SEM. Data was analyzed using a one-way 
ANOVA, two-factor ANOVA, or repeated measures ANOVA with post hoc comparisons 
analyzed using Fisher’s test of least square difference where appropriate. Statistical 




Prism 7.0 (GraphPad Software Inc., La Jolla, CA) or the R statistical programming 







High fat-sedentary mice weighed significantly more than all other groups from 
week 2 until the completion of the study. High fat-exercise and ketogenic mice also 
gained significantly more weight than control-fed sedentary mice across the final 6 weeks 
of the study, though both groups remained below high fat-sedentary mice weights (Fig. 
2a). High fat-exercise and ketogenic mice consumed the greatest amount of energy (Fig. 
2b). High fat-sedentary mice displayed a significant increase in fat mass as a percent of 
their body weight compared to all other groups (high fat-sedentary vs. control-fed 
sedentary p<0.0001; high fat-sedentary vs. high fat-exercise p<0.0001; high fat-sedentary 
vs. ketogenic p=0.0028). Additionally, high fat-exercise and ketogenic mice have 
increased fat mass as compared to control-fed sedentary mice (high fat-exercise vs. 
control-fed sedentary p<0.0001; ketogenic vs. control-fed sedentary p<0.0001), though 
less than high fat-sedentary. Though there was no difference in body weight, ketogenic 
mice had greater fat mass than high fat-exercised mice (p=0.0420) (Fig. 2c). Blood 
ketones were consistently elevated in ketogenic diet-fed mice compared to all other 










Figure 4.2.  (a) A high fat diet causes weight gain relative to all groups, while exercise or 
a ketogenic diet displays weight gain relative to standard diet controls (n=18 for all 
groups). (b) High fat exercised and ketogenic fed mice display increased energy intake 
relative to sedentary controls (n=18 for all groups) (c) A high fat diet causes fat mass 
gains relative to all groups, while exercise or a ketogenic diet display fat mass gains 
relative to standard controls, and a ketogenic diet displays greater fat mass as compared 
to HF-Ex mice (n=18 for all groups) (d) Ketogenic fed mice experience increased serum 
ketone levels after 1 week with a decrease over time while still remaining slightly 
elevated compare to all other groups All data presented as mean ± SEM  *:CF-Sed vs. 
HF-Sed #: Keto vs. HF-Sed ^: HF-Sed vs. HF-Ex +: HF-Ex vs. CF-Sed °: Keto vs. CF-



















Blood Measures of Prediabetes 
 High fat-sedentary, high fat-exercise, and ketogenic mice had mildly elevated 
blood glucose levels compared to control-fed sedentary counterparts beginning after 2 
weeks of dietary intervention for high fat-sedentary and ketogenic mice and 4 weeks for 
high fat-exercise mice (Fig. 3a). Fasting insulin was significantly elevated in high fat-fed 
mice (high fat-sedentary vs. control-fed sedentary p<0.001; high fat-sedentary vs. 
ketogenic p<0.0001; high fat-exercise vs. control-fed sedentary p<0.0001; high fat-
exercise vs. ketogenic p<0.0001), but was not altered in ketogenic fed mice compared to 
control-fed sedentary mice (Fig. 3c). High fat-sedentary mice displayed significantly 
increased blood glucose levels during IPGTT at 60 and 120 minutes compared to control-
fed mice (Fig 3b). HOMA-IR, a measure of beta cell function and insulin resistance, was 
significantly increased in high fat-fed mice but was unaltered in ketogenic fed mice (high 
fat-sedentary vs. control-fed sedentary p<0.001; high fat-sedentary vs. ketogenic 
p<0.0001; high fat-exercise vs. control-fed sedentary p<0.0001; high fat-exercise vs. 
ketogenic p<0.0001) (Fig 3d).   
Changes in Sensory Thresholds 
 After six weeks, high fat-sedentary and high fat-exercise mice displayed 
decreased thresholds in mechanical sensitivity, though only high fat-sedentary mice were 




exercise vs. control-fed sedentary p=0.0565; high fat-sedentary vs. ketogenic p=0.0482; 
high fat-exercise vs. ketogenic p =0.094). After 8 weeks, mechanical thresholds in high 
fat-exercise mice began to return towards baseline threshold levels, while high fat-
sedentary mice still exhibited heightened sensitivity (high fat-sedentary vs. control-fed 
sedentary p =0.0421; high fat-sedentary vs. ketogenic p=0.0161). After 12 weeks, high 
fat-sedentary mice continued to display mechanical allodynia, while high fat-exercise 
returned to baseline mechanical thresholds (high fat-sedentary vs. ketogenic p=0.0136; 
high fat-sedentary vs. control-fed sedentary p=0.0702; high fat-sedentary vs. high fat-
exercise p=0.0658) (Fig. 5a). Throughout the course of the study, no groups displayed 
















Figure 4.3. (a) A high fat diet in both exercised and sedentary mice, or a ketogenic diet, 
slightly increase blood glucose levels relative to control mice, through hyperglycemia 
does not develop in any group (n=18 for all groups). (b) A high fat diet in sedentary mice 
reduces IPGTT relative to control mice, while ketogenic animals display no significant 
alteration from controls (n=5 for all groups). (c) After 12 weeks, a high fat diet increases 
serum insulin levels as compared to both ketogenic and control diet animals. (d) A high 
fat diet regardless of exercise increases HOMA-IR values as compared to both control 
and ketogenic-fed animals. All data presented as mean ± SEM *: CF-Sed vs. HF-Sed #: 
Keto vs. HF-Sed ^: HF-Sed vs. HF-Ex +: HF-Ex vs. CF-Sed °: Keto vs. CF-Sed $: Keto 



















Intervention Obesity Measures 
All groups were initially started on a high fat diet at 8 weeks of age. Following 8 
weeks of being fed a high fat diet, these mice were then divided into different groups 
based on their diet and exercise intervention. High fat-sedentary and ketogenic mice 
weighed significantly more than all other groups from week 2 until the completion of the 
study. High fat-exercise mice also gained significantly more weight than mice switched 
to a control-fed diet (Fig. 4a). Control-fed sedentary mice were the only group to display 
a decrease in body weight from baseline measures. Ketogenic diet-fed mice in the obesity 
intervention consumed the greatest amount of energy, mirroring their increased body 
weight compared to other groups (Fig. 4b). Elevated fat mass mirrored bodyweight 
alterations, as high fat-sedentary and ketogenic mice displayed significant increases in fat 
mass as a percent of their body weight compared to all other groups. High fat-exercise 
mice maintained their fat mass below high fat-sedentary and ketogenic mice, yet above 
control-fed sedentary mice (Fig. 4c). Mice switched to a control-fed sedentary diet had 
significantly less fat mass as compared to all other groups. 
Intervention Blood Measures of Prediabetes 
Only mice switched to a control-fed sedentary diet displayed a decrease in blood 
glucose levels (Fig. 4d). Fasting insulin levels at sacrifice were significantly reduced in 




fat-sedentary p<0.05) and high fat-exercised (control-fed sedentary vs. high fat-exercise 
p<0.01) mice. Mice switched to a ketogenic diet had insulin levels between control-fed 
sedentary and high fat-sedentary mice, although not significantly different (Fig. 4e). Only 
mice switched to a control-fed sedentary diet showed a decrease in HOMA-IR as 


















Figure 4.4. (a) A high fat diet in both exercised and sedentary mice, or a ketogenic diet, 
slightly increase blood glucose levels relative to control mice, through hyperglycemia 
does not develop in any group (n=18 for all groups) (b) Following 8 weeks of a HF 
diet, mice switched to a ketogenic diet still consume the most energy per day (c) 
Following 8 weeks of a HF diet, mice given access to a voluntary running wheel or a 
control diet display a reduction in fat mass (n=10 for all groups) d) Following 8 weeks 
of a HF diet, only a CF-Sed intervention reduced blood glucose levels over the next 12 
weeks (n=10 for all groups)  (e) CF-Sed rescue cohort animals experience a rescue of 
insulin levels, while Keto animals show neither an increase from CF-Sed animals nor a 
decrease from either HF diet group. (f) Following 8 weeks of a HF diet, only CF-Sed 
intervention experience a rescue of HOMA-IR, while Keto animas show neither an 
increase from CF-Sed nor a decrease from HF diet groups. All data presented as mean 
± SEM  #: HF-Sed vs. Keto ^: HF-Sed vs. HF-Ex °: CF-Sed vs. Keto ∇: HF-Ex vs. 
















Intervention Changes in Sensory Thresholds 
Following 8 weeks of a high fat diet, all groups displayed mechanical allodynia. 
However, 4 weeks after dietary intervention, only ketogenic diet-fed mice displayed a 
significant increase in mechanical thresholds to near an expected standard baseline value 
for hind paw sensation, which was maintained until sacrifice (ketogenic vs. high fat-
sedentary p=0.0033; ketogenic vs. control-fed sedentary p=0.0119; ketogenic vs. high 
fat-exercise p=0.0426) (Fig. 5c). No other groups displayed changes in their mechanical 

















Figure 4.5. (a) Von Frey mechanical sensitivity examination shows sensitivity in HF-Sed 
animals compared to control animals beginning at 4 weeks, and compared to Keto 
animals beginning at 6 weeks (b) Hargreaves’s thermal sensitivity examination displayed 
no alterations in sensitivity regardless of diet or exercise. (c) Only ketogenic animals 
experience a reduction in mechanical sensitivity to levels following 8 weeks of a HF-Sed 
diet. All data presented as mean ± SEM *: CF-Sed vs. HF-Sed #: Keto vs. HF-Sed * $: 






















Alteration in Pain Associated Genes 
 A principal components analysis (PCA) was applied to a preselected set of 25 
pain-associated genes to understand whether variation in expression of pain-associated 
genes was related to dietary and exercise intervention. Collectively, the top 3 principal 
components explained 72.6% of variation across the 25 pain-associated genes, with 
36.5%, 22.2%, and 13.9% of variation explained by the first, second, and third principal 
component (PC), respectively. Associations between both the first and third PC and 
dietary and exercise intervention group were observed (p = 0.061 and p = 0.006 for PC1 
and PC3, respectively), with the first PC reaching only borderline statistical significance. 
High fat-exercised animals displayed a unique profile compared to all other groups based 
on PC1 and PC3, as indicated in Fig. 6a. To understand which pain-related genes were 
responsible for the unique profile exhibited by high fat-exercised mice, we conducted a 
differential expression analysis comparing gene expression between high fat-exercised 
mice and all other dietary and exercise intervention groups. Asic3 (p = 9.68E-6), Ntrk1 (p 
=0.001), and Prkaca (p = 3.09E-4) were significantly down regulated, whereas P2rx3 (p = 
0.011), Scn10a (p = 0.015), Ret (p = 0.013), Scn11a (p = 0.009), and Prkca (p = 0.011) 




















Figure 4.6.  (a) Genes were grouped into components that statistically describe the 
greatest variation between groups, and subsequent principal component analysis (PCA) 
of these groups of pain-associated genes displays a unique profile for high fat-exercised 
animals as compared to all other groups. (b) Heat map of pain associated genes following 
12 weeks of diet and exercise interventions. Red represents increased mRNA expression, 
and green represents decreased gene expression. Each vertical lane represents gene 
changes for a single mouse. Genes significantly different between groups highlighted in 
yellow dashed boxes (genes utilized for PC1 top yellow box, genes utilized for PC3 







































 There exists increasing evidence of the association in the rise of metabolic 
syndrome and obesity with the development of various pain syndromes 212. This has 
driven an emergence of research to combat these changes in sensation driven by these 
disorders 17,180,182,215. Our results reaffirm that a high fat diet leads to numerous metabolic 
changes representative of prediabetes, including mechanical allodynia. In addition, we 
have shown that compared to a high fat diet, consumption of a ketogenic diet, does not 
lead to the development of mechanical allodynia. Similarly, a ketogenic diet is associated 
with lower insulin levels. Importantly, the consumption of a ketogenic diet reversed pre-
existing mechanical allodynia related to the long-term consumption of a high fat diet 
independent of changes in other metabolic parameters. As an interesting comparison, a 
control diet, lead to restoration of improved metabolic outcomes but failed to reverse 
established mechanical allodynia. This data begins to identify complex relationships 
between biomarkers of metabolic status and peripheral nerve and nociceptive function, 
and suggests that these relationships may be independently altered by either exercise or 
dietary interventions. Importantly, these results suggest for the first time that a ketogenic 
diet may improve nociception associated with obesity and prediabetes that may be 






Ketogenic Diet and Metabolic Changes 
Previous studies have demonstrated that a high fat diet can serve as a valuable 
approach to model obesity, increased fat mass, and insulin resistance 17,180,215. Here, mice 
fed a high fat diet predictably developed increased body weight and fat deposition, mildly 
increased blood glucose and increased insulin levels. Exercise was able to prevent 
increases in body weight and fat deposition despite any changes in elevated blood 
glucose and insulin levels. Thus, exercise was able to blunt several but not all metabolic 
changes associated with a high fat diet consistent with previous studies 215. Similar to 
exercise, a ketogenic diet also resulted in comparatively reduced body weight and fat 
deposition but was unable to lower blood glucose. One important distinction is that the 
ketogenic diet did not lead to hyperinsulinemia similar to a high fat diet or exercised mice 
on a high fat diet, consistent with previous studies 219. A role for insulin and insulin 
resistance in sensory function, nociception and neuropathy is becoming increasingly 
important. Our results are consistent with the idea that insulin levels may be a key 
modulator of peripheral nerve function and that insulin resistance has a negative impact 
on nociception 220-224.  
 Another important aspect of this study analyzed whether a ketogenic diet could be 
used as an intervention to improve poor metabolic control and pre-existing nociceptive 
changes induced by a high fat diet. As noted above, a high fat diet leads to symptoms 
resembling prediabetes and only a change to the control diet was able to return mice to 




to increase their body weight, fat deposition, blood glucose and insulin similar to 
sedentary mice fed a high fat diet. Contrary to our expectations, exercise initiated eight 
weeks after consuming a high fat diet was unable to correct metabolic maladies. High fat-
exercise mice saw no reduction in insulin levels; however previous work did show high 
fat-exercise mice do show improved glucose tolerance 17. Though exercise blunted 
increases in some metabolic measures, its overall effect exhibited maintenance of the 
starting metabolic status without improvements to normal levels. Together, these results 
are somewhat surprising as neither exercise nor a ketogenic diet led to significant 
improvements in metabolic parameters when used as an intervention after consuming a 
high fat diet for eight weeks. 
 
Sensory Changes Accompanying a High Fat or Ketogenic Diet 
The impact of a ketogenic diet on sensation and neuropathy has received little 
attention. Previous research reported changes in thermal sensitivity in both juvenile and 
adult rats when fed a ketogenic diet 100,101. In the current study, mice never displayed 
changes in thermal sensitivity in response to a high fat or a ketogenic diet, suggesting that 
there may be important species differences involved in changes associated with changes. 
In contrast, mechanosensation was quite sensitive to dietary and metabolic changes. 
Similar to previous studies, a high fat diet led to the development of mechanical allodynia 
17,215. Importantly, high-fat diet induced allodynia was corrected by exercise 17,215. We 




mechanical allodynia. This suggests that despite the elevated fat content in both the 
ketogenic and high fat diet, the amount and utilization of the fat appears to be important. 
In concordance, our experiments to intervene with a ketogenic diet after consuming a 
high fat diet for 8 weeks led to remarkable improvements in mechanosensation compared 
to mice fed a high fat diet with or without exercise or even using a control diet 
intervention. Interestingly, mice switched to a control diet had a reversal in all metabolic 
parameters, but failed to reduce the high fat diet induced mechanical allodynia. We 
postulate that the failure by a control diet to improve mechanosensation could be due to 
metabolic memory of peripheral pathways. If true, it is plausible to suggest that a 
ketogenic diet may be able to overcome or reset metabolic memory in sensory 
components that convey mechanosensation, and lead to a reduction in allodynia or pain 
associated with prediabetes. 
 
Genetic Alterations With A High-Fat Diet and Exercise 
 A high fat diet and exercise drives numerous alterations in peripheral nerves, 
including the development of mechanical sensitivity 17,124,180,182,215. Analysis of lumbar 
DRG mRNA expression of selected pain-associated genes revealed that high fat-fed 
exercised animals developed unique changes in mRNA expression in genes that 
associated with pain. Moreover, this analysis revealed that ketogenic and high fat-
exercised animals do not show the same patterns in mRNA expression changes. The 




suggest that exercise intervention may have a more direct impact on sensory neuron 
function through changes in specific genes important to nociception. Down-regulation of 
key genes associated with ASIC3 signaling suggests there may be anti-inflammatory 
signaling occurring at the level of the DRG. It also suggests that the powerful effect of 
the ketogenic diet may utilize other mechanisms to provide benefits on nociception. 
These may include reduced peripheral inflammation from non-neuronal tissues, 
modulation of central inhibitory systems, and alterations in glutamate levels or signaling, 
which are postulated actions of a ketogenic diet associated with epilepsy treatment 225. It 
is clear that the effects of a ketogenic diet merit further investigation, including the 
breadth of its effect on other forms of nociceptive, nociplastic and neuropathic pain.  
 
Conclusion 
 Our current research reveals that a ketogenic diet provides significant benefits to 
the peripheral nervous system. A ketogenic diet did lead to obesity and increased fat 
deposition, but not hyperinsulinemia or mechanical allodynia. Exercise can also provide 
benefits, but it appears that these benefits may be through unique mechanisms and lead to 
specific changes in gene expression in the DRG. The ability of a ketogenic diet to not 
only prevent, but to also reverse mechanical allodynia highlights the exciting potential for 











Chapter 5  












The growing epidemic of obesity and diabetes has led to a dramatic increase in 
various pain syndromes and a personal as well as economic burden. A common 
complication associated with diabetes and metabolic syndrome is a loss of small fibers in 
the skin and increased pain 226,227. With the development of metabolic syndrome, some 
have proposed that there is a loss of axonal regenerative capacity leading to a loss of 
small fibers that in diabetes 228. The current work examined metabolic, sensory, and 
molecular benefits on peripheral nerves from consuming a ketogenic diet. Previous 
examination of the effects of a ketogenic diet has primarily focused on the central 
nervous system and has shown to offer significant benefits to neurons. Caloric restriction 
increases ketone metabolism and can be a pro-growth signaling agent in the hippocampus 
and dentate gyrus 229,230. However, the mechanism and function of increased neuronal 
growth is still under investigation.  
The regulation of axonal growth and epidermal innervation has been studied by 
others intensely as the ability to innervate skin and re-grow nerves would be a profound 
therapeutic tool for not only diabetes, but also numerous other neuropathic diseases. One 
important signaling mechanism regulating nerve growth is the presence of the 
neurotrophins nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), and 
glial derived neurotrohpic factor (GDNF)231. During development, expression of 
neurotrophins at target tissues is a key signal for axonal growth and innervation232. The 




through HDAC inhibition108,233. Neurotrophins can provide analgesic relief to numerous 
nociceptive states, and the stimulation of neurotrophin expression by ketone bodies is 
consistent with newly reported analgesic benefits of a ketogenic diet 234-237.   
The metabolism of ketones has been studied in numerous peripheral tissues, but a 
role for ketone metabolism in the peripheral nervous system is not clear. Studies have 
shown that metabolism of ketones in peripheral tissues increases peroxisome proliferator 
activated receptors, which in turn reduce inflammatory states in disease 104,105. Analysis 
of the molecular alterations of ketone metabolism also revealed benefits to mitochondrial 
metabolism that improve anti-inflammatory signaling and may identify important 
mechanisms associated with ketone metabolism. 
Ketone-based metabolism produces less reactive oxygen species (ROS) compared 
to glucose metabolism at a mitochondrial and cellular level 106. In neurons, reductions in 
ROS due to caloric restriction/ketone signaling may occur due to alterations in Complex I 
of the respiratory chain. In addition, ketones inhibit ROS production through an increase 
in NAD/NADH ratios while metabolizing beta-hydroxybutyrate as compared to 
glutamate107. This alteration in NAD/NADH ratio activates Sirt1, which inhibits 
apoptotic and inflammatory signaling while promoting increase mitochondrial 
biogenesis107. Improved mitochondrial respiration may offset detrimental mitochondrial 
changes associated with increased calcium signaling from neuronal injury to improve 




The present study investigates effects of ketone metabolism in peripheral nerves 
and its potential to alter nerve metabolism in settings of obesity and diabetes. Here, we 
address potential benefits of a ketogenic diet on peripheral axon growth, and compare 
them with consumption of a detrimental high fat diet or potential benefits of exercise. In 
summary, mice fed a ketogenic diet display improved axonal growth that may be 
stimulated by ketones. Additionally, mice fed a ketogenic diet show adaptations in 
mitochondria to a fat based fuel source, with reduced ROS production. This adaptation 
identifies an important mechanism that may explain anti-inflammatory associated 
benefits of a ketogenic diet on peripheral nerves.  
Experimental Procedure 
Diet and Mice 
Seven-week-old male C57/BL6 #027 mice were purchased from Charles River 
(Wilmington, Mass) and maintained on a 12:12h light/dark cycle in the research support 
facility at the University of Kansas Medical Center. All mice were given ad libitum 
access to food and water and were fed either a standard chow diet (8604; Envigo, 
Madison Wisconsin; 14% kcals from fat, 32% protein, and 54% carbohydrate), a high-fat 
diet (07011; Envigo; 54% kcals from vegetable shortening (hydrogenated) and corn oil 
fat, 21% protein and 24% carbohydrate), or a ketogenic diet (96355; Envigo; 90.5% kcals 
from vegetable shortening (hydrogenated) and corn oil fat, 9.2% protein, and 0.3% 
carbohydrate). Two cohorts of mice were utilized to examine the effects of dietary and 




standard diet through all baseline testing. After baseline behavioral testing was complete, 
mice were separated and the groups were given different diets to form the following 
groups: control-fed, high fat diet-sedentary, high fat diet-exercised, and ketogenic diet. 
The second cohort henceforth referred to as ‘obesity intervention cohort’ mice were all 
fed a high-fat diet for eight weeks and through baseline testing. After baseline behavioral 
testing was complete, mice were separated and the groups were given different diets or 
intervention. All mice were 8 weeks of age at the start of diet and exercise. A timeline of 
diet and exercise intervention for both cohorts is the same as Chapter 4, Figure 4.1. All 
animal use was in accordance with NIH guidelines and conformed to the principles 
specified in a protocol approved by the University of Kansas Medical Center Institutional 
Animal Care and Use Committee.  
Intraepidermal Nerve Fiber Density (IENFD) 
Footpads were collected and processed from both cohorts of mice as previously 
described for intraepidermal nerve fiber density 17.  
Neurite Outgrowth 
Lumbar DRGs 4-6 neurons were harvested and dissociated to a single cell 
suspension as previously described 238. Mice were fed the control, high-fat, or ketogenic 
diet described above for four weeks prior to DRG dissection. Upon plating, all mice were 
given F-12 media with 10mM glucose for 4 days. Additional culture experiments utilized 




supplemented with varying levels of glucose (0mM, 5mM, 10mM) and/or (R)-(-)-3–
hydroxybutyric acid (5mM or 10mM) (Sigma). Following the 4 days in culture, neurons 
were fixed with 4% paraformaldehyde for 10 minutes. Immunohistochemistry was 
performed with SMI-312 (Covance, Emeryville, CA), a pan-axonal marker, to visualize 
neurites and counterstained with nuclear marker, Hoechst 33342 (Invitrogen). Coverslips 
were mounted on slides and imaged. Neurite outgrowth area was quantified using Image 
J. A stereological grid was superimposed on images of the cultures, and the number of 
neurites crossing exactly through intersections of the grid was counted, as was the 
number of neuronal cell bodies producing neurites. Three regions of interest were imaged 
per coverslip, and three coverslips per group were analyzed for each animal and the 
neurite area per neuron was calculated according to the following equation 239: 
𝒏𝒆𝒖𝒓𝒊𝒕𝒆 𝒊𝒏𝒕𝒆𝒓𝒔𝒆𝒄𝒕𝒊𝒐𝒏𝒔
𝒕𝒐𝒕𝒂𝒍 𝒈𝒓𝒊𝒅 𝒊𝒏𝒕𝒆𝒓𝒔𝒆𝒄𝒕𝒊𝒐𝒏𝒔
× 𝒕𝒐𝒕𝒂𝒍 𝒈𝒓𝒊𝒅 𝒂𝒓𝒆𝒂
𝒏𝒆𝒖𝒓𝒐𝒏𝒔 𝒆𝒙𝒕𝒆𝒏𝒅𝒊𝒏𝒈 𝒏𝒆𝒖𝒓𝒊𝒕𝒆𝒔 = 𝒏𝒆𝒖𝒓𝒊𝒕𝒆 𝒂𝒓𝒆𝒂 µ𝒎
𝟐 𝒑𝒆𝒓 𝒏𝒆𝒖𝒓𝒐𝒏 
ELISA’s 
 Following sacrifice, L4-L6 DRG and sciatic nerve were dissected out, snap frozen 
in liquid nitrogen, and stored at -80C until analysis. Tissue samples were homogenized 
and quantified for protein as previously described 17. Proteins for BDNF (Abnova, Taipei 
City, Taiwan) and GDNF (Abcam, Cambridge UK) were quantified using an ELISA kit 





 Mitochondrial respiration and ROS production was assessed using high-resolution 
respirometry and fluorescence (Oroboros Oxygraph-2k; Oroboros Instruments; 
Innsbruck, Austria). DRG or SN were permealized with 10µl digitonin and initially 
placed in respiration chambers in respiration media (MiR05; sucrose, 110 mM; KMES, 
60 mM; EGTA, 0.5 mM; MgCl2, 3 mM; KH2PO4, 10 mM; HEPES, 20 mM; Glucose, 
20mM; adjusted to pH 7.1 with KOH at 37C; and 1 g/L fatty acid free BSA) for 
assessment of basal respiration (Basal). Oxygen flux was measured by addition of 
palmitoyl-CoA (2mM) and malate (.8M) to the chambers in the absence of ADP (GM-
State 2) for assessment of State 2 respiration. Oxidative phosphorylation (OXPHOS) with 
electron flux through complex I was then quantified by addition of ADP (.5M) for 
assessment of State 3 respiration. Maximal ADP respiration with electron flux through 
both complex I and complex II was assessed by the addition of succinate (1M) 
(Succinate: State 3-Complex I+II).  
RNAseq 
Total RNA for the first cohort of mice was extracted with TruSeq Stranded 
mRNA Library Prep kit (Illumina, CA). Six biological replicates were used for each 
dietary and exercise intervention group, for a total of 24 samples. Pair-end sequencing 
was performed using the Illumina platform with read length of 100 bp and an insert size 
of 160 bp. FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) was used 
to access sequence quality, with manual inspection of the results before proceeding to 




parameters. Within RSEM, we used the bowtie2217 as mapping tool and the mouse mm10 
genome assembly as the reference genome.  
The Bioconductor package “edgeR”218 was used for preprocessing the raw gene 
count data. Gene count data were normalized by library size and genes with non/low 
transcription were removed. With regard to the latter, genes with expression level >1 cpm 
in at least 2 out of the 24 samples were retained, resulting in a total of ~16,000 genes that 
were considered for subsequent statistical analyses. The resulting genes were than used to 
perform KEGG pathway analysis to examine all genes associated with known pathways. 
Axonal guidance and mitochondrial oxidative phosphorylation pathways were examined 
for differences between ketogenic and control-fed mice. These alterations shown before 
are relative gene expression differences, and have not been analyzed for statistically 
significant alterations but are instead utilized to show full complete pathway changes.  
Statistical Analyses 
 All data is presented as mean ± SEM. Data was analyzed using a one-way 
ANOVA, two-factor ANOVA, or repeated measures ANOVA with post hoc comparisons 
analyzed using Fisher’s test of least square difference where appropriate. Statistical 
significance was defined as p <0.05 and all statistics were run using GraphPad Prism 7.0 






Intraepidermal Nerve Fiber Density 
 Nerve fiber densities were altered by both diet and exercise, though in opposing 
fashions. Nerve fiber density is decreased by exercise (CF-Sed vs. HF-Ex p=0.0002; HF-
Sed vs. HF-Ex p=0.0017; Keto vs. HF-Ex p<0.0001) and increased with a ketogenic diet 
(CF-Sed vs. Keto p=0.0496; HF-Sed vs. Keto p=0.0225; HF-Ex vs. Keto p<0.0001) (Fig. 
1c). 
 Obesity Intervention Cohort: Mice placed on a ketogenic diet display an increase 
in nerve fiber density compared to all groups (Keto vs. CF-Sed p=0.0158; Keto vs. HF-
Sed p=0.0033; Keto vs. HF-Ex p<0.0001). HF-Ex mice display decreased nerve fiber 












Figure 5.1. (a) Epidermal innervation of ketogenic mice following 12 weeks of diet (b) 
Epidermal innervation of animals placed on ketogenic diet following 8 weeks of a high fat 
diet c) Ketogenic diet-fed mice display increase epidermal nerve fiber density as compared to 
all other groups, while high fat-exercised mice display decrease nerve fiber density as 
compared to all groups (d) Obesity intervention cohort ketogenic-fed mice again display 
increased epidermal nerve fiber density as compared to all other groups, while high fat-
exercised mice again display decreased nerve fiber density as compared to control-fed mice. 



















 Following four weeks of dietary intervention, primary cultured neurons from mice 
fed a ketogenic diet and grown in 10mM glucose F12 media displayed increased neurite 
outgrowth compared to a control (p=0.0197) or high fat (p=0.001) diet (Fig. 2c). A 
follow up examination of neurons from control diet-fed mice displayed increased neurite 
outgrowth when grown in media containing 5mM Glucose and 5mM Ketones (p=0.001) 
and 10mM Ketone and 0mM Glucose (p=0.0343) as compared to standard 10mM 

















Figure 5.2. (a) Neurite outgrowth of primary DRG cultured in 10mM glucose F12 media 
from mice fed a ketogenic diet for four weeks prior to sacrifice (b) Neurite outgrowth 
from primary DRG cultured in 5mM glucose 5mM ketone (c). Mice fed a ketogenic diet 
one month prior to culture display improved neurite outgrowth as compared to mice fed a 
control or high fat diet when all placed in 10mM F12 media (d) DRG cultured in F12 
media supplemented with 5mM ketones and 5mM glucose or 10mM ketones display 
improved neurite outgrowth as compared to traditional 10mM glucose media. All data 





















 DRG harvested in vivo following 12 weeks of dietary or exercise protocols 
display no differences in GDNF or BDNF protein levels (Fig. 3). Sciatic nerves from 
high fat-sedentary mice show significantly increased GDNF protein levels compared to 
control-fed (p=0.034) and ketogenic-fed (p<0.0001) mice; while high fat-exercise mice 





















Figure 5.3. (a) GDNF protein levels from DRG of mice following 12 weeks of diet or 
exercise intervention (n=8 for all groups) (b) GDNF protein levels from sciatic nerves of 
mice following 12 weeks of diet or exercise intervention (n=8 for all groups) (c) BDNF 
protein levels from DRG of mice following 12 weeks of diet or exercise intervention 
(n=7 for all groups) (d) BDNF protein levels from sciatic nerves of mice following 12 
weeks of diet or exercise intervention (n=7 for all groups). All data presented as mean ± 











Figure 5.3 Dietary and Exercise Effects on Neurotrophin Protein Level in Mouse 








A Ketogenic Diet Alters mRNA Expression of Genes Important in Axon Growth  
 RNAseq was used to analyze expression patterns of known mRNAs associated 
with axon growth and/or inhibition in lumbar DRGs from ketogenic-fed mice following 
12 weeks on the diet. This analysis reveals a trend of increased expression of axonal 
outgrowth-associated genes (NFAT, PLCγ, UNC5, EphA, Par3, Par6, SSH, BMP7, WNT 
signaling), as well as apparent decreases in mRNA encoding axon inhibitory signals 
compared to control-fed mice (CXCR4, Cdc42, Rac, Cofilin, CRMP, TRPC, CAamKII, 
Ptch1) (Fig. 4).  
Additional mRNA analysis revealed that a ketogenic diet resulted in increased 
mRNA expression from the NADH dehydrogenase (Complex I), cytochrome c reductase 
(Complex III) cytochrome c oxidase (Complex IV) compared to control-fed mice (Fig. 
5). Complex I associated genes: Ndufs, Ndufa, Ndufb, Ndufc; Complex III associated 












Figure 5.4. Relative mRNA expression of axonal guidance pathway genes in DRG of 
mice fed a ketogenic diet to control-fed mice. Within each gene in the below figure, all 6 
animals from the ketogenic-fed mice are represented by colored bars for their expression 
relative to control mice. Green indicates a decrease in relative expression, red represents 
an increase in relative expression, and gray represents no difference from control-fed 
























Figure 5.5. Relative gene expression of oxidative phosphorylation complex genes in 
DRG of mice fed a ketogenic diet to control-fed mice. Within each gene in the below 
figure, all 6 animals from the ketogenic-fed mice are represented by colored bars for their 
expression relative to control mice. Green indicates a decrease in relative expression, red 
represents an increase in relative expression, and gray represents no difference from 
























Mitochondrial Respiration of Fat Metabolism in DRG 
 DRG neurons display no differences in basal or maximal respiration of palmitoyl-
CoA following 10 weeks among a high-fat, ketogenic, or control diet (Fig. 6a & 6b). 
DRG also show no change in H2O2 flux, a measure of ROS production, during 
metabolism of palmitoyl-CoA regardless of diet (Fig. 6c & 6d).  
Mitochondrial Respiration of Fat Metabolism in Sciatic Nerve 
 Sciatic nerves from control-fed mice have elevated basal (p=0.03) and maximal 
(p=0.02) oxidative respiration from palmitoyl-CoA as compared to high fat-fed mice 
(Fig. 7a & 7b). Sciatic nerves from ketogenic-fed mice have decreased H2O2 flux during 
maximal respiration (p=0.019), a sign of reduced ROS production when metabolizing 

















Figure 5.6. (a) Basal ADP dependent (State III) respiratory rate of DRG following 10 
weeks of diet (b) Maximal respiratory rate of DRG (c) State III rate of ROS production in 


























Figure 5.7. (a) Basal ADP dependent (State III) respiratory rate of SN following 10 
weeks of diet (b) Maximal respiratory rate of SN (c) State III rate of ROS production in 

























The growing epidemic of obesity and metabolic syndrome is coupled with an 
increase in distal symmetric sensorimotor polyneuropathy (DSPN), one of the most 
common forms of peripheral neuropathy. DSPN is classically characterized by a dying 
back phenotype in which the distal tip of the axon retreats or degenerates. This axonal 
degeneration is commonly accompanied with pain and/or numbness in the extremities 240. 
To this point there have been limited therapies to help intervene or rescue this dying back 
neuropathy241,242. Neurite outgrowth has been show to be increased in mice lacking the 
acetylcholine receptor, and M1R null mice given streptozotocin to induce diabetic 
neuropathy did not see a reduction in neuronal innervation241. The only other intervention 
to improve diabetic neuropathy increased Hsp70 in sensory neurons to improve insulin 
and IGF1 signaling providing protection against neurodegeneration in diabetic 
phenotypes243. The work presented here shows that a ketogenic diet can increase 
cutaneous innervation, even in mice with obesity and metabolic syndrome. One proposed 
mechanism of metabolic dysfunction leading to a dying back neuropathy is an increase in 
mitochondrial dysfunction and increased oxidative stress 244. Here we also show that 
mitochondria in DRGs from mice fed a ketogenic diet adapt to fat based fuel sources with 
reduced oxidative stress compared to mice fed a traditional diet. Together these results 
provide a potential new intervention using a ketogenic diet for conditions associated with 





Nerve Density & Outgrowth 
 A common complication associated with diabetes and metabolic syndrome is a 
loss of small fibers in the skin and increased pain 226,227. With the development of 
metabolic syndrome, some have proposed that there is a loss of axonal regenerative 
capacity leading to a loss of small fibers that is a common complication of diabetes 228. 
Currently, there are few approaches that have attempted to prevent or rescue this loss of 
innervation associated with neuropathy 241,242,245,246. The present results may offer 
extremely attractive new interventions to prevent a loss of innervation and perhaps rescue 
and promote an increase in nerve growth. 
Analysis of IENF density in mice fed different diets revealed that a ketogenic diet 
resulted in a 10% increase in IENF density compared to mice fed a high fat diet. This was 
also true in mice that received a ketogenic diet as an intervention from established 
obesity. Further, in vitro experiments revealed that DRG axon growth was enhanced in 
mice that were fed a ketogenic diet for 4 weeks. It is interesting that high fat-exercised 
mice displayed a decrease in IENFD despite having a reduction in mechanical allodynia, 
perhaps again highlighting disparate mechanisms by which exercise and a ketogenic diet 
reduce mechanical allodynia, as seen in Chapter 4. Additional in vitro experiments in 
mice fed a control diet revealed that DRG neurons supplemented with either only 
ketones, or ketones and glucose displayed increased axonal growth compared to DRG 




ketogenic diet and ketone bodies themselves may alter metabolism that promotes axon 
integrity and/or axon growth. 
Recent evidence suggests that ketone bodies can stimulate neurotrophin 
production via inhibition of HDAC108. Based on the extensive evidence that 
neurotrophins are powerful stimulators of axon growth231,232, we examined whether the 
expression of two neurotrophins, BDNF and GDNF was altered in the DRG or sciatic 
mice within our study. Our results revealed that GDNF and BDNF levels were reduced in 
the sciatic nerves of ketogenic fed mice with no alterations in the DRG for any dietary 
group. This could suggest that the ketogenic-fed mice experience improved shuttling and 
use of the neurotrophins from the distal end of the axon. Compartmentalization of 
neurotrophins and the timing of these changes are likely complex, and further study is 
needed to elucidate how ketone bodies and neurotrophin signaling may be linked when 
consuming a ketogenic diet. However, increases in neurotrophin levels could suggest 
increased pro-growth signaling is responsible for the improved IENFD observed in mice 
fed a ketogenic diet.  
After completing RNAseq analysis of genes relevant to axonal guidance pathway 
signaling for the entire know pathway, the pathway picture suggests that a ketogenic diet 
alters axonal guidance related gene expression. The genes represented in the pathway 
analysis were not required to be individually statistically significant; instead, they were 
denoted as changes by individual mice relative to controls. The trend of genes suggest the 




but also suggest a reduction in the axonal repulsion signals that can arise. The gene 
expression changes that signal attraction while reducing repulsion signaling could be the 
reason for such significant INEFD changes in both prevention and recovery models as 
seen in Fig 1. Moreover, this may offer signaling with the ability to respond to counter 
axonal repulsion and death signaling during disease states. 
 
Mitochondrial Function & Respiration  
 One potential mechanism underlying poor peripheral nerve function may be the of 
abnormal mitochondrial function and increase oxidative stress 244. This theory is based on 
the idea that in mitochondrial metabolism, an increase in ROS leads to increased lipid 
peroxidation and impaired mitochondrial function in the axon. Collectively, this may lead 
to axonal degeneration and death 247. The primary alteration observed in mitochondrial 
oxidation besides increased ROS production was a reduction of genes associated with the 
enzymatic activity of Complex’s I and IV 247.  
 Our present research suggests that consumption of a ketogenic diet may benefit 
peripheral nerves by improving mitochondrial function. RNAseq analysis of changes in 
mRNA expression of genes important in oxidative phosphorylation pathways displayed 
increased gene expression of NADH Dehydrogenase (Complex I) genes, as well as a 
decrease in cytochrome C oxidase (Complex IV) genes in ketogenic-fed mice relative to 
controls. This suggests that contrary to control diet-fed mice, axonal growth in ketogenic 




since it has been reported that mitochondrial function and gene expression is negatively 
altered in the sensory neurons of animal models of type 1 diabetes220.   
 Ketones inhibit ROS production through an increase in NAD/NADH ratios, and 
our results are consistent with this view 107. In our study, the decrease in mitochondrial 
H2O2 flux in sciatic nerves during steady state and maximal respiration shows ketogenic-
fed animals have a direct decrease in ROS production when metabolizing fats. This key 
metabolic improvement may provide the key adaptation which neurons adapt to 
metabolizing fats by a ketogenic diet. The changes in mitochondrial function were only 
observed in the sciatic nerve, suggesting that more peripherally-located mitochondria are 
more susceptible to metabolic dysfunction than those in the neuronal cell body. This also 
agrees with literature that the more distal nerves are the most susceptible to metabolic 
dysfunction when modeling diabetes248.  
Conclusion 
 The present work highlights the important impact of dietary changes on peripheral 
axon growth, gene expression, and mitochondrial function. We have shown that a 
ketogenic diet promotes peripheral axon growth and improves mitochondrial function. 
Here, we provide evidence that peripheral neurons can use a fat based fuel source and can 
adapt to this fuel source. The ability to use dietary interventions to improve axonal 
growth and function in settings of axon degeneration is an important step forward for a 






















Summary and Findings 
Obesity has risen to a global epidemic and with this rise has come a subsequent 
increase in the rates of cardiovascular disease, metabolic syndrome, and diabetes. This 
rapid increase in obesity-related disease has also driven increases in biomedical research 
to combat these common diseases. However, this research is often reserved to selected 
tissues such as skeletal muscle, cardiac tissue, and the liver. Research limited to these 
traditional tissues has resulted in insufficient knowledge on other peripheral organs that 
are affected by obesity. This dissertation focused on the peripheral nervous system and 
how obesity, metabolic syndrome, diet, and exercise affect sensation and pain. Our goal 
was to conduct experiments to examine mechanical allodynia, metabolic syndrome, 
inflammation, and mitochondrial reactive oxygen species production in an effort to 
understand the effects of altered metabolism on obesity related alterations such as 
diabetic neuropathy. 
Initial work in this dissertation examined the effect of genetic regulation of 
aerobic capacity using a model of genetic variance in metabolic syndrome. Our analysis 
of female HCR and LCR rats displayed profound changes in female LCR rats associated 
with fat mass, inflammatory signals, and mechanosensation. These findings are consistent 
with the view that the peripheral nervous system is susceptible to metabolic changes 
known to be important in human disease. Next, studies examined the role of a high fat 
diet and exercise on metabolic syndrome-induced mechanical allodynia. Mice fed a high 
fat diet and allowed to exercise developed significant changes in inflammation, 




leading to decreased circulating ketones. This work led to the discovery that a ketogenic 
diet is extremely beneficial to peripheral nerve sensation and growth. Thus, the final 
studies in this dissertation examined the effect of an extremely high fat, low carbohydrate 
‘ketogenic’ diet on the function, sensitivity, and growth of peripheral nerves. Together 
the present results show that the peripheral nervous system is altered by metabolic insults, 
and in turn adaptable to physical activity and dietary changes. Significantly, our results 
reveal that a ketogenic diet is beneficial to mitochondrial function, mechanosensation, 
and axonal growth in peripheral nerves.  Together, these studies highlight a potential new 
intervention for millions of individuals experiencing neuropathic symptoms associated 




This chapter utilized low capacity running (LCR) and high capacity (HCR) rats to 
examine the underlying mechanisms by which high and low aerobic capacity impacts 
peripheral nerves. LCR and HCR rats are commonly used in physiological studies 
designed to understand mechanisms and genetics associated with exercise, activity and 
disease risk. We compared a number of pain- and neuropathy-relevant features of the 
peripheral nervous system in female LCR and HCR rats on a control diet to understand 
baseline alterations due to only inbred aerobic capacity.  
The LCR and HCR rats allow for a unique model of inherit genetic variance in 
respiratory fitness, which also manifest as increased metabolic syndrome induced 




rats is associated with alterations in fat mass and mechanosensation. In LCR female rats, 
clear differences were evident in increased fat mass and increased inflammatory cells in 
the skin. Obesity, coupled with an increased presence of inflammatory cells suggests that 
low aerobic capacity in LCR rats can heighten inflammatory responses in the peripheral 
nervous system. This peripheral nerve inflammatory response can then affect 
mechanosensation by perhaps priming the system for future insults. It was interesting to 
observe the relationship between body weight, fat mass, and sensory changes. This 
revealed the novel but important finding that peripheral nerves have altered function that 
are independent of whole body changes in weight and fat mass.  
Chapter 3 
 
In this chapter, mice were placed on a control or high fat diet and allowed access 
to either a sedentary or exercise wheel environment for 12 weeks. High fat-sedentary and 
high fat-exercised mice developed mechanical allodynia and metabolic syndrome over 6 
weeks. High fat-exercised mice however, experienced a return to basal levels of 
mechanosensation by week 12. High-fat sedentary animals experienced elevated fat mass 
and displayed alterations in inflammatory mediators in the peripheral nerves. Our results 
revealed that a high fat diet increases expression of pro-inflammatory mRNAs in DRGs 
and these changes in gene expression could be reduced with physical activity. These 
changes were coupled with improvements in mechanosensation and provide additional 
evidence that inflammatory pathways in the peripheral nervous system are important in 




We found that the benefits of exercise on the nervous system are not mediated via 
increased fat metabolism alone, since high fat exercised mice have increased fat pad mass 
and burn fats as a primary fuel source, while expending less resting energy than high-fat 
fed sedentary mice. Often exercise is thought to increase metabolism, decrease obesity 
and fat mass, thereby decreasing proinflammatory signaling61. However, our results differ 
from this view based on decreased pro-inflammatory signaling in the peripheral nerves 
without any improvement in obesity or fat mass.   
Lastly, mice fed a high-fat diet but allowed to exercise displayed improved ketone 
processing and similar utilization of fat compared to high fat-fed sedentary animals. 
Increase ketone utilization and decreased expression of mediators associated with 
inflammation led to questions of whether a ketogenic diet could impact peripheral nerves 
and mechanosensation in Chapters 4 & 5. Results in Chapter 3 suggests that there are 
molecular alterations that occur in peripheral nerves due to altered fat 
metabolism/increased utilization of ketones. In turn, this alteration in metabolism may 
play a key role in the improvement in mechanosensation observed with physical activity.  
Chapter 4 
 
This chapter examined mice placed on a control, high fat, high fat with exercise, 
or ketogenic diet for 12 weeks. Follow up studies examined these same dietary groups 
following 8 weeks of a high fat diet to induce obesity and metabolic syndrome. These 
studies suggested that the peripheral nervous system is sensitive to metabolic insults but 




hypothesis that benefits of exercise are through altered peripheral nerve metabolism. A 
ketogenic diet led to obesity and increased fat deposition, but did not impact 
hyperinsulinemia or lead to mechanical allodynia similar to a high fat diet. Another 
unique alteration with a ketogenic diet is that the gene expression patterns of pain-
associated genes were different from high fat-exercised animals. A high fat diet leads to 
mechanical allodynia; whereas both exercise and a ketogenic diet result in normal 
mechanosensation. Importantly however, only a ketogenic diet could reverse mechanical 
allodynia that was previously induced by a high fat diet. These differences in pain 
reduction and gene expression profiles suggest that a ketogenic diet has actions that are 
unique from those mediated by exercise. 
We also examined the ability of dietary and exercise therapies to correct obesity 
as a result of a high fat diet. One interesting result from this study was that once C57Bl/6 
mice became obese from consuming a high fat, interventions using either a control diet or 
exercise failed to return mice to normal weight or metabolic biomarkers.  In addition, the 
ability of a ketogenic diet to reverse mechanical allodynia highlights the exciting 
potential for a dietary intervention for patients with metabolic syndrome-associated pain. 
Perhaps increased ketones through dietary intervention provided a greater benefit to 
nociceptive sensations, and our work lays the groundwork for further work on ketone 
metabolism and pain. The cellular and tissue-wide mechanisms impacted by a ketogenic 






In this chapter, studies examined the role of a ketogenic diet and ketones in 
altering peripheral nerve metabolism (mitochondrial respiration and ROS production) and 
axonal growth. Examination of skin from mice fed a ketogenic diet display increased 
innervation even after the development of obesity and metabolic syndrome. To 
understand the cause of increased skin innervation, studies utilized a ketogenic diet and 
primary cultures of DRG neurons in the presence of ketone molecules and in response to 
consumption of a ketogenic diet. Additional work examined respiration in mitochondria 
from DRG neurons and sciatic nerve when using fat a primary source of fuel. 
Increased IENF density and improved in vitro neuronal outgrowth with a 
ketogenic diet or ketone supplementation is a groundbreaking observation. Ketone 
supplementation to cultured neurons displayed significantly better axonal growth as 
compared to glucose-based fuel sources. Additionally, animals fed a ketogenic diet for 1 
month prior to primary cell culture, or control diet fed mice cultured in the presence of 
ketone bodies displayed significantly increased axonal outgrowth. Overall, the 
improvement in axonal growth and function from a ketogenic diet offers a new 
therapeutic intervention for a myriad of neuropathies, including DSPN. 
DRG and sciatic nerves were analyzed in response a fat based fuel source to 
explore the role of fat metabolism in neurons. Mice fed a ketogenic diet displayed 
improved mitochondrial function when metabolizing fats as evident by reduced ROS 




adaptation to a fat as fuel may provide significant functional benefits to peripheral axons 
and suggests that peripheral nerves can adapt to fat as a fuel source.  
Clinical Implications 
The use of physical exercise and as a therapeutic treatment to specifically address 
pain is a relatively new and developing field. The goal of metabolic alterations to benefit 
painful neuropathies by diet and exercise is an even newer field. The majority of research 
on exercise for peripheral pain syndromes in human subjects is associated with diabetic 
or pre-diabetic neuropathic pain. The few studies that have utilized physical activity are 
displayed in Table 6.1 Importantly, however, it has been reported by numerous groups 
that exercise can be performed safely in patients with type 2 diabetic neuropathies and 
exercise intervention produces a marked improvement in certain neurological disorders 
249,250.  Historically, clinicians may have been reluctant to encourage exercise in patients 
with diabetic neuropathy due to the risk of possible adverse outcomes such as foot ulcers 
in insensate feet or increased pain. However, the results of the present work clearly show 
there is a new and exciting potential that may achieve some of the healthy benefits of 
























Aerobic exercise is an often-studied modality in clinical programs for people with 
diabetes. Diabetics have experienced a benefit in both motor and sensory neuropathy 
measures. Aerobic exercise reduces the development of diabetic neuropathy 32, as well as 
increasing the intraepidermal nerve fiber density (IENFD) and visual analog scale (VAS) 
pain measure in people with diabetes 228,249,251-253. Similarly, exercise induced 
improvement in metabolic syndrome patients saw an increase in cutaneous IENFD even 
though these patients were non-diabetic 228. The exciting finding that a ketogenic diet 
increases axon growth offers a potential to translate a new therapy into the human 
population suffering from an axonal degeneration. Physical exercise when paired with 
diet counseling has already been shown to result in partial cutaneous re-innervation in 
pre-diabetic individuals 252. The potential to pair exercise with a ketogenic diet may offer 
an attractive new therapy for patients.  
Throughout the studies we performed, we noted effects of exercise and a 
ketogenic diet on inflammatory signaling. The potential to reduce inflammatory 
responses in peripheral nerves is an extremely attractive translational finding, as there are 
a myriad of peripheral diseases associated with heightened inflammatory responses. 
Some common neuropathic inflammatory conditions such as Guillain-Barré Syndrome 
(GBS), chronic inflammatory demyelinating polyneuropathy (CIPD), and multifocal 
motor neuropathy may benefit from a ketogenic diet. The integration of both acute (GBS) 
and chronic (CIPD) inflammatory conditions in peripheral neuropathies can make the 
combat of inflammatory conditions often difficult needing to have short term and long 




quickly (~1-3 weeks) even when used as an intervention to correct a neuropathic 
symptom. Long term utilization of a ketogenic diet may be difficult in a human 
population, though it has been utilized for >6 months in humans to combat CIPD already 
254. 
While there are numerous potential benefits from a ketogenic diet for patients, 
such as being able to help those unable or willing to exercise, the most significant benefit 
may be increased axonal growth. One of the most common forms of peripheral 
neuropathy is distal symmetric sensorimotor polyneuropathy (DSPN). DSPN involves a 
dying back phenotype where the most distal part of the axon retreats with accompanying 
pain and/or numbness in the extremities 240. DSPN is often associated with metabolic 
diseases such as diabetes, hypothyroidism, vitamin deficiencies and chronic liver disease. 
Our present work on metabolic syndrome and the ketogenic diet is an extremely 
attractive intervention. This potential dietary tool to rescue axonal loss that affects 
millions of patients in the US may provide the first therapeutic intervention of its kind to 






The above work presents some attractive mechanisms to combat numerous 
ailments beyond the peripheral nerve disease. However, this is still much to be 
understood about the effects of not only a ketogenic diet, but also metabolic syndrome in 
diseases and in nervous tissue itself. Following these studies, future work should examine 
the molecular adaptations, which occur in peripheral nerves in an effort to deduce the 
crucial steps in ketone signaling. Based on the current results, I hypothesize that the most 
productive avenues are anti-inflammatory pathways, improved mitochondrial function 
and decreased ROS production. Additionally, analgesia could be mediated by increased 
A1R activation and anti-inflammatory actions. Finally, future research should continue to 
identify cellular mechanisms used by the ketone β-hydroxybutyrate to stimulate axonal 
growth.  
In addition to providing an inflammatory response, adenosine and its receptor can 
provide analgesic relief through its direct signaling in sensory nerves. As described in 
Chapter 1, adenosine increases with a ketogenic diet, and is involved in analgesic benefits 
during exercise as well. Future work should examine the role of adenosine in the 
analgesic benefit of a ketogenic diet in metabolic and obesity-induced pain. Experiments 
should examine the production of ATP in sensory neurons with a ketogenic diet. 
Increased energy output in combination with increase adenosine levels may be important 




 Increased ATP production likely would result from improved mitochondrial 
respiration. Therefore, future work should look to examine mitochondrial respiration and 
expand on the discovery of decreased ROS production from a fat fuel source in the DRG. 
Research in diabetic neuropathy has already recognized the importance of oxidative 
stress in the development of sensory dysfunction in peripheral neurons 255,256. One 
attractive mechanism of future studies is the NRF2/ROS pathway, which displays 
potential overlap with ketogenic alterations. The utilization of a ketogenic diet may 
reduce ROS through an increase in NADH/NAD ratio, inducing antioxidant response 
elements (AREs) that are promoted by the transcription factor NRF2 257. This pathway 
has shown to alter by insulin signaling in pancreatic beta-cells and it is possible a 
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